{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:22:12Z","timestamp":1791901332052,"version":"4.3.4"},"reference-count":285,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SAN No: 102\/IFD\/SAN\/2549\/2019-20"],"award-info":[{"award-number":["SAN No: 102\/IFD\/SAN\/2549\/2019-20"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRPIG-2023-0001508"],"award-info":[{"award-number":["IIRPIG-2023-0001508"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/005004"],"award-info":[{"award-number":["CRG\/2022\/005004"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Protein translation is essential for maintaining the optimal functioning of the human nervous system. The 4E-Binding proteins (4E-BPs) are central regulators of this process, acting on the initiation factor eIF4E. Three homologs 4E-BP1, 4E-BP2, and 4E-BP3, are differentially expressed, with the phosphorylation state controlling cap-dependent translation in response to diverse physiological inputs, including growth factors, cytokines, hormones, nutrient availability, and signaling cascades converging on kinases such as mTOR. Dysregulation of 4E-BP activity has been implicated in multiple disease contexts, including neurodegenerative disorders (e.g., Parkinson\u2019s disease, Alzheimer\u2019s disease), neurodevelopmental disorders (e.g., Autism spectrum disorder, Epilepsy), neuropsychiatric conditions (e.g., Depression, Schizophrenia), and autoimmune diseases (e.g., Multiple sclerosis, Guillain\u2013Barr\u00e9 syndrome). We aim to explore the importance of 4E-BPs through a neurological perspective and understand their role as therapeutic targets. In this review, we provide a comprehensive analysis of the three 4E-BP homologs in the central nervous system, emphasizing the CNS-specific dominance of 4E-BP2 and its link to synaptic plasticity and cognitive function. We further examine and provide mechanistic insights into how 4E-BPs contribute to disease pathogenesis, highlighting both shared and disorder-specific features. Finally, we discuss current therapeutic strategies aimed at modulating the mTOR\/4E-BP axis, outline the limitations of existing approaches and identify emerging avenues for drug development. Together, these perspectives underscore the potential of 4E-BPs as both therapeutic targets and biomarkers in neurological disease.<\/jats:p>","DOI":"10.1007\/s12035-025-05553-6","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:38:03Z","timestamp":1764020283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The 4E-BPs as Translational Regulators in Neurological Disorders: Molecular Mechanisms and Therapeutic Potential"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0192-9423","authenticated-orcid":false,"given":"Sindhu S.","family":"Baskarapantula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5098-2589","authenticated-orcid":false,"given":"Venkata Surya","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7756-6197","authenticated-orcid":false,"given":"Priyajit","family":"Changdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0142-7941","authenticated-orcid":false,"given":"Debashree","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0508-1394","authenticated-orcid":false,"given":"Yogendra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6151-2964","authenticated-orcid":false,"given":"Albert R.","family":"La Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5847-1687","authenticated-orcid":false,"given":"Craig L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4123-1801","authenticated-orcid":false,"given":"Somasish G.","family":"Dastidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"5553_CR1","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","volume":"13","author":"A-C Gingras","year":"1999","unstructured":"Gingras A-C, Gygi SP, Raught B et al (1999) Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13:1422\u20131437. https:\/\/doi.org\/10.1101\/gad.13.11.1422","journal-title":"Genes Dev"},{"key":"5553_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00726-008-0100-3","volume":"35","author":"X-H Liao","year":"2008","unstructured":"Liao X-H, Majithia A, Huang X, Kimmel AR (2008) Growth control via TOR kinase signaling, an intracellular sensor of amino acid and energy availability, with crosstalk potential to proline metabolism. Amino Acids 35:761\u2013770. https:\/\/doi.org\/10.1007\/s00726-008-0100-3","journal-title":"Amino Acids"},{"key":"5553_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M et al (2023) Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther 8:375. https:\/\/doi.org\/10.1038\/s41392-023-01608-z","journal-title":"Signal Transduct Target Ther"},{"key":"5553_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","volume":"12","author":"PB Crino","year":"2016","unstructured":"Crino PB (2016) The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12:379\u2013392. https:\/\/doi.org\/10.1038\/nrneurol.2016.81","journal-title":"Nat Rev Neurol"},{"key":"5553_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejcb.2017.03.013","volume":"96","author":"A Batool","year":"2017","unstructured":"Batool A, Aashaq S, Andrabi KI (2017) Reappraisal to the study of 4E-BP1 as an mTOR substrate \u2013 a normative critique. Eur J Cell Biol 96:325\u2013336. https:\/\/doi.org\/10.1016\/j.ejcb.2017.03.013","journal-title":"Eur J Cell Biol"},{"key":"5553_CR6","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.2174\/0929867329666220224112042","volume":"29","author":"C Maracci","year":"2022","unstructured":"Maracci C, Motta S, Romagnoli A et al (2022) The mTOR\/4E-BP1\/eIF4E signalling pathway as a source of cancer drug targets. Curr Med Chem 29:3501\u20133529. https:\/\/doi.org\/10.2174\/0929867329666220224112042","journal-title":"Curr Med Chem"},{"key":"5553_CR7","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1038\/onc.2015.515","volume":"35","author":"J Musa","year":"2016","unstructured":"Musa J, Orth MF, Dallmayer M et al (2016) Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis. Oncogene 35:4675\u20134688. https:\/\/doi.org\/10.1038\/onc.2015.515","journal-title":"Oncogene"},{"key":"5553_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/15384101.2016.1151581","volume":"15","author":"X Qin","year":"2016","unstructured":"Qin X, Jiang B, Zhang Y (2016) 4E-BP1, a multifactor regulated multifunctional protein. Cell Cycle 15:781\u2013786. https:\/\/doi.org\/10.1080\/15384101.2016.1151581","journal-title":"Cell Cycle"},{"key":"5553_CR9","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/onc.2016.363","volume":"36","author":"LC Kim","year":"2017","unstructured":"Kim LC, Cook RS, Chen J (2017) mTORC1 and mTORC2 in cancer and the tumor microenvironment. Oncogene 36:2191\u20132201. https:\/\/doi.org\/10.1038\/onc.2016.363","journal-title":"Oncogene"},{"key":"5553_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jcb.30433","volume":"124","author":"K Verma","year":"2023","unstructured":"Verma K, Jaiswal R, Paliwal S et al (2023) An insight into PI3k\/Akt pathway and associated protein\u2013protein interactions in metabolic syndrome: a recent update. J Cell Biochem 124:923\u2013942. https:\/\/doi.org\/10.1002\/jcb.30433","journal-title":"J Cell Biochem"},{"key":"5553_CR11","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11010-022-04587-x","volume":"478","author":"K Ramasubbu","year":"2023","unstructured":"Ramasubbu K, Devi Rajeswari V (2023) Impairment of insulin signaling pathway PI3K\/Akt\/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review. Mol Cell Biochem 478:1307\u20131324. https:\/\/doi.org\/10.1007\/s11010-022-04587-x","journal-title":"Mol Cell Biochem"},{"key":"5553_CR12","doi-asserted-by":"publisher","first-page":"14071","DOI":"10.1074\/jbc.R109.094003","volume":"285","author":"KG Foster","year":"2010","unstructured":"Foster KG, Fingar DC (2010) Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 285:14071\u201314077. https:\/\/doi.org\/10.1074\/jbc.R109.094003","journal-title":"J Biol Chem"},{"key":"5553_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed A, Kim E, Jacinto E (2021) Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev 101:1371\u20131426. https:\/\/doi.org\/10.1152\/physrev.00026.2020","journal-title":"Physiol Rev"},{"key":"5553_CR14","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1038\/sj.onc.1209888","volume":"25","author":"Y Mamane","year":"2006","unstructured":"Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N (2006) mTOR, translation initiation and cancer. Oncogene 25:6416\u20136422. https:\/\/doi.org\/10.1038\/sj.onc.1209888","journal-title":"Oncogene"},{"key":"5553_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1517\/14728220903241625","volume":"13","author":"F Robert","year":"2009","unstructured":"Robert F, Pelletier J (2009) Translation initiation: a critical signalling node in cancer. Expert Opin Ther Targets 13:1279\u20131293. https:\/\/doi.org\/10.1517\/14728220903241625","journal-title":"Expert Opin Ther Targets"},{"key":"5553_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrm2838","volume":"11","author":"RJ Jackson","year":"2010","unstructured":"Jackson RJ, Hellen CUT, Pestova TV (2010) The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11:113\u2013127. https:\/\/doi.org\/10.1038\/nrm2838","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5553_CR17","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1073\/pnas.111145798","volume":"98","author":"TV Pestova","year":"2001","unstructured":"Pestova TV, Kolupaeva VG, Lomakin IB et al (2001) Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci U S A 98:7029\u20137036. https:\/\/doi.org\/10.1073\/pnas.111145798","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5553_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033092","volume":"10","author":"WC Merrick","year":"2018","unstructured":"Merrick WC, Pavitt GD (2018) Protein synthesis initiation in eukaryotic cells. Cold Spring Harb Perspect Biol 10:a033092. https:\/\/doi.org\/10.1101\/cshperspect.a033092","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5553_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1146\/annurev.biochem.68.1.913","volume":"68","author":"A-C Gingras","year":"1999","unstructured":"Gingras A-C, Raught B, Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913\u2013963. https:\/\/doi.org\/10.1146\/annurev.biochem.68.1.913","journal-title":"Annu Rev Biochem"},{"key":"5553_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1042\/BC20080104","volume":"101","author":"S Chatterjee","year":"2009","unstructured":"Chatterjee S, Pal JK (2009) Role of 5\u2032- and 3\u2032-untranslated regions of mRNAs in human diseases. Biol Cell 101:251\u2013262. https:\/\/doi.org\/10.1042\/BC20080104","journal-title":"Biol Cell"},{"key":"5553_CR21","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1016\/j.cell.2022.10.005","volume":"185","author":"J Wang","year":"2022","unstructured":"Wang J, Shin B-S, Alvarado C et al (2022) Rapid 40S scanning and its regulation by mRNA structure during eukaryotic translation initiation. Cell 185:4474-4487.e17. https:\/\/doi.org\/10.1016\/j.cell.2022.10.005","journal-title":"Cell"},{"key":"5553_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s42003-022-03534-2","volume":"5","author":"I Basu","year":"2022","unstructured":"Basu I, Gorai B, Chandran T et al (2022) Selection of start codon during mRNA scanning in eukaryotic translation initiation. Commun Biol 5:587. https:\/\/doi.org\/10.1038\/s42003-022-03534-2","journal-title":"Commun Biol"},{"key":"5553_CR23","doi-asserted-by":"publisher","first-page":"31827","DOI":"10.1074\/jbc.M114.602870","volume":"289","author":"M Sokabe","year":"2014","unstructured":"Sokabe M, Fraser CS (2014) Human eukaryotic initiation factor 2 (eIF2)-GTP-Met-tRNAi ternary complex and eIF3 stabilize the 43 S preinitiation complex. J Biol Chem 289:31827\u201331836. https:\/\/doi.org\/10.1074\/jbc.M114.602870","journal-title":"J Biol Chem"},{"key":"5553_CR24","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1101\/gad.1255704","volume":"18","author":"A Unbehaun","year":"2004","unstructured":"Unbehaun A, Borukhov SI, Hellen CUT, Pestova TV (2004) Release of initiation factors from 48S complexes during ribosomal subunit joining and the link between establishment of codon-anticodon base-pairing and hydrolysis of eIF2-bound GTP. Genes Dev 18:3078\u20133093. https:\/\/doi.org\/10.1101\/gad.1255704","journal-title":"Genes Dev"},{"key":"5553_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbapap.2005.07.023","volume":"1753","author":"K Tomoo","year":"2005","unstructured":"Tomoo K, Matsushita Y, Fujisaki H et al (2005) Structural basis for mRNA cap-binding regulation of eukaryotic initiation factor 4E by 4E-binding protein, studied by spectroscopic, X-ray crystal structural, and molecular dynamics simulation methods. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1753:191\u2013208. https:\/\/doi.org\/10.1016\/j.bbapap.2005.07.023","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"key":"5553_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1097-2765(01)80003-4","volume":"3","author":"J Marcotrigiano","year":"1999","unstructured":"Marcotrigiano J, Gingras A-C, Sonenberg N, Burley SK (1999) Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. Mol Cell 3:707\u2013716. https:\/\/doi.org\/10.1016\/S1097-2765(01)80003-4","journal-title":"Mol Cell"},{"key":"5553_CR27","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1093\/nar\/gkq1306","volume":"39","author":"P Gosselin","year":"2011","unstructured":"Gosselin P, Oulhen N, Jam M et al (2011) The translational repressor 4E-BP called to order by eIF4E: new structural insights by SAXS. Nucleic Acids Res 39:3496\u20133503. https:\/\/doi.org\/10.1093\/nar\/gkq1306","journal-title":"Nucleic Acids Res"},{"key":"5553_CR28","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/ncomms5790","volume":"5","author":"C Igreja","year":"2014","unstructured":"Igreja C, Peter D, Weiler C, Izaurralde E (2014) 4E-bps require non-canonical 4E-binding motifs and a lateral surface of eIF4E to repress translation. Nat Commun 5:4790. https:\/\/doi.org\/10.1038\/ncomms5790","journal-title":"Nat Commun"},{"key":"5553_CR29","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1101\/gad.912401","volume":"15","author":"A-C Gingras","year":"2001","unstructured":"Gingras A-C, Raught B, Gygi SP et al (2001) Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15:2852\u20132864. https:\/\/doi.org\/10.1101\/gad.912401","journal-title":"Genes Dev"},{"key":"5553_CR30","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/psc.1384","volume":"17","author":"A Fukuyo","year":"2011","unstructured":"Fukuyo A, In Y, Ishida T, Tomoo K (2011) Structural scaffold for eIF4E binding selectivity of 4E-BP isoforms: crystal structure of eIF4E binding region of 4E-BP2 and its comparison with that of 4E-BP1. J Pept Sci 17:650\u2013657. https:\/\/doi.org\/10.1002\/psc.1384","journal-title":"J Pept Sci"},{"key":"5553_CR31","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.1074\/jbc.273.22.14002","volume":"273","author":"F Poulin","year":"1998","unstructured":"Poulin F, Gingras A-C, Olsen H et al (1998) 4E-BP3, a new member of the eukaryotic initiation factor 4E-binding protein family. J Biol Chem 273:14002\u201314007. https:\/\/doi.org\/10.1074\/jbc.273.22.14002","journal-title":"J Biol Chem"},{"key":"5553_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1006\/geno.1996.0638","volume":"38","author":"K Tsukiyama-Kohara","year":"1996","unstructured":"Tsukiyama-Kohara K, Vidal SM, Gingras A-C et al (1996) Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4E-binding proteins 1 and 2. Genomics 38:353\u2013363. https:\/\/doi.org\/10.1006\/geno.1996.0638","journal-title":"Genomics"},{"key":"5553_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001679","volume":"11","author":"O Yogev","year":"2013","unstructured":"Yogev O, Williams VC, Hinits Y, Hughes SM (2013) eIF4EBP3L acts as a gatekeeper of TORC1 in activity-dependent muscle growth by specifically regulating Mef2ca translational initiation. PLoS Biol 11:e1001679. https:\/\/doi.org\/10.1371\/journal.pbio.1001679","journal-title":"PLoS Biol"},{"key":"5553_CR34","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1080\/15384101.2016.1224786","volume":"15","author":"Y Tsukumo","year":"2016","unstructured":"Tsukumo Y, Sonenberg N, Alain T (2016) Transcriptional induction of 4E-BP3 prolongs translation repression. Cell Cycle 15:3325\u20133326. https:\/\/doi.org\/10.1080\/15384101.2016.1224786","journal-title":"Cell Cycle"},{"key":"5553_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11776","volume":"7","author":"Y Tsukumo","year":"2016","unstructured":"Tsukumo Y, Alain T, Fonseca BD et al (2016) Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3. Nat Commun 7:11776. https:\/\/doi.org\/10.1038\/ncomms11776","journal-title":"Nat Commun"},{"key":"5553_CR36","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/acs.jctc.9b01042","volume":"16","author":"W Kang","year":"2020","unstructured":"Kang W, Jiang F, Wu Y-D, Wales DJ (2020) Multifunnel energy landscapes for phosphorylated translation repressor 4E-BP2 and its mutants. J Chem Theory Comput 16:800\u2013810. https:\/\/doi.org\/10.1021\/acs.jctc.9b01042","journal-title":"J Chem Theory Comput"},{"key":"5553_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0014-5793(02)03694-3","volume":"532","author":"M Kleijn","year":"2002","unstructured":"Kleijn M, Scheper GC, Wilson ML et al (2002) Localisation and regulation of the eIF4E-binding protein 4E-BP3. FEBS Lett 532:319\u2013323. https:\/\/doi.org\/10.1016\/S0014-5793(02)03694-3","journal-title":"FEBS Lett"},{"key":"5553_CR38","doi-asserted-by":"publisher","first-page":"9581","DOI":"10.1523\/JNEUROSCI.2423-05.2005","volume":"25","author":"JL Banko","year":"2005","unstructured":"Banko JL, Poulin F, Hou L et al (2005) The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the hippocampus. J Neurosci 25:9581\u20139590. https:\/\/doi.org\/10.1523\/JNEUROSCI.2423-05.2005","journal-title":"J Neurosci"},{"key":"5553_CR39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1042\/bj2040817","volume":"204","author":"PJ Blackshear","year":"1982","unstructured":"Blackshear PJ, Nemenoff RA, Avruch J (1982) Preliminary characterization of a heat-stable protein from rat adipose tissue whose phosphorylation is stimulated by insulin. Biochem J 204:817\u2013824. https:\/\/doi.org\/10.1042\/bj2040817","journal-title":"Biochem J"},{"key":"5553_CR40","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2022.36.S1.R3610","author":"GN Kincheloe","year":"2022","unstructured":"Kincheloe GN, Roberson PA, Toro AL et al (2022) 4E-BP1\/2 deletion enhances mRNA cap-binding complex assembly and protein synthesis in immobilized skeletal muscle but is not sufficient to prevent muscle atrophy. FASEB J. https:\/\/doi.org\/10.1096\/fasebj.2022.36.S1.R3610","journal-title":"FASEB J"},{"key":"5553_CR41","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/1873-3468.13721","volume":"594","author":"DC Mitchell","year":"2020","unstructured":"Mitchell DC, Menon A, Garner AL (2020) Cyclin-dependent kinase 4 inhibits the translational repressor 4E-BP1 to promote cap-dependent translation during mitosis\u2013G1 transition. FEBS Lett 594:1307\u20131318. https:\/\/doi.org\/10.1002\/1873-3468.13721","journal-title":"FEBS Lett"},{"key":"5553_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1152\/japplphysiol.00563.2022","volume":"134","author":"GN Kincheloe","year":"2023","unstructured":"Kincheloe GN, Roberson PA, Toro AL et al (2023) Loss of 4E-BPs prevents the hindlimb immobilization-induced decrease in protein synthesis in skeletal muscle. J Appl Physiol 134:72\u201383. https:\/\/doi.org\/10.1152\/japplphysiol.00563.2022","journal-title":"J Appl Physiol"},{"key":"5553_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282914","volume":"18","author":"S Cao","year":"2023","unstructured":"Cao S, Jurczak MJ, Shuda Y et al (2023) Mitotic CDK1 and 4E-BP1 II: a single phosphomimetic mutation in 4E-BP1 induces glucose intolerance in mice. PLoS ONE 18:e0282914. https:\/\/doi.org\/10.1371\/journal.pone.0282914","journal-title":"PLoS ONE"},{"key":"5553_CR44","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.molcel.2021.03.031","volume":"81","author":"R B\u00f6hm","year":"2021","unstructured":"B\u00f6hm R, Imseng S, Jakob RP et al (2021) The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1. Mol Cell 81:2403-2416.e5. https:\/\/doi.org\/10.1016\/j.molcel.2021.03.031","journal-title":"Mol Cell"},{"key":"5553_CR45","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1073\/pnas.91.9.3730","volume":"91","author":"C Hu","year":"1994","unstructured":"Hu C, Pang S, Kong X et al (1994) Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. Proc Natl Acad Sci U S A 91:3730\u20133734. https:\/\/doi.org\/10.1073\/pnas.91.9.3730","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5553_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1126\/science.7939721","volume":"266","author":"T-A Lin","year":"1994","unstructured":"Lin T-A, Kong X, Haystead TAJ et al (1994) PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266:653\u2013656. https:\/\/doi.org\/10.1126\/science.7939721","journal-title":"Science"},{"key":"5553_CR47","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/371762a0","volume":"371","author":"A Pause","year":"1994","unstructured":"Pause A, Belsham GJ, Gingras A-C et al (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5\u2019-cap function. Nature 371:762\u2013767. https:\/\/doi.org\/10.1038\/371762a0","journal-title":"Nature"},{"key":"5553_CR48","doi-asserted-by":"publisher","first-page":"23185","DOI":"10.1016\/S0021-9258(17)31637-X","volume":"269","author":"TA Haystead","year":"1994","unstructured":"Haystead TA, Haystead CM, Hu C et al (1994) Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in rat adipocytes. J Biol Chem 269:23185\u201323191. https:\/\/doi.org\/10.1016\/S0021-9258(17)31637-X","journal-title":"J Biol Chem"},{"key":"5553_CR49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.bbrc.2020.04.086","volume":"527","author":"A Batool","year":"2020","unstructured":"Batool A, Majeed ST, Aashaq S et al (2020) Eukaryotic initiation factor 4E phosphorylation acts a switch for its binding to 4E-BP1 and mRNA cap assembly. Biochem Biophys Res Commun 527:489\u2013495. https:\/\/doi.org\/10.1016\/j.bbrc.2020.04.086","journal-title":"Biochem Biophys Res Commun"},{"key":"5553_CR50","doi-asserted-by":"publisher","first-page":"E636","DOI":"10.1152\/ajpendo.00464.2019","volume":"318","author":"Y Toyoshima","year":"2020","unstructured":"Toyoshima Y, Yoshizawa F, Tokita R et al (2020) A translation repressor, 4E-BP1, regulates the triglyceride level in rat liver during protein deprivation. Am J Physiol-Endocrinol Metab 318:E636\u2013E645. https:\/\/doi.org\/10.1152\/ajpendo.00464.2019","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"5553_CR51","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1128\/MCB.15.9.4990","volume":"15","author":"S Mader","year":"1995","unstructured":"Mader S, Lee H, Pause A, Sonenberg N (1995) The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4\u03b3 and the translational repressors 4E-binding proteins. Mol Cell Biol 15:4990\u20134997. https:\/\/doi.org\/10.1128\/MCB.15.9.4990","journal-title":"Mol Cell Biol"},{"key":"5553_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/bi972494r","volume":"37","author":"CM Fletcher","year":"1998","unstructured":"Fletcher CM, McGuire AM, Gingras A-C et al (1998) 4E binding proteins inhibit the translation factor eIF4E without folded structure. Biochemistry 37:9\u201315. https:\/\/doi.org\/10.1021\/bi972494r","journal-title":"Biochemistry"},{"key":"5553_CR53","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1074\/jbc.AAC120.013398","volume":"295","author":"R Sun","year":"2020","unstructured":"Sun R, Cheng E, Vel\u00e1squez C et al (2020) Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E). J Biol Chem 295:4760. https:\/\/doi.org\/10.1074\/jbc.AAC120.013398","journal-title":"J Biol Chem"},{"key":"5553_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.109927","volume":"244","author":"J Zou","year":"2024","unstructured":"Zou J, Wu B, Tao Y et al (2024) Inhibition of the rapamycin-insensitive mTORC1 \/4E-BP1 axis attenuates TGF-\u03b21-induced fibrotic response in human Tenon\u2019s fibroblasts. Exp Eye Res 244:109927. https:\/\/doi.org\/10.1016\/j.exer.2024.109927","journal-title":"Exp Eye Res"},{"key":"5553_CR55","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.4103\/1673-5374.371372","volume":"18","author":"J Jiang","year":"2023","unstructured":"Jiang J, Zhang L, Zou J et al (2023) Phosphorylated S6K1 and 4E-BP1 play different roles in constitutively active Rheb-mediated retinal ganglion cell survival and axon regeneration after optic nerve injury. Neural Regen Res 18:2526\u20132534. https:\/\/doi.org\/10.4103\/1673-5374.371372","journal-title":"Neural Regen Res"},{"key":"5553_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282722","volume":"18","author":"R Sun","year":"2023","unstructured":"Sun R, Guo S, Shuda Y et al (2023) Mitotic CDK1 and 4E-BP1 I: loss of 4E-BP1 serine 82 phosphorylation promotes proliferative polycystic disease and lymphoma in aged or sublethally irradiated mice. PLoS ONE 18:e0282722. https:\/\/doi.org\/10.1371\/journal.pone.0282722","journal-title":"PLoS ONE"},{"key":"5553_CR57","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/pro.5560070720","volume":"7","author":"CM Fletcher","year":"1998","unstructured":"Fletcher CM, Wagner G (1998) The interaction of eIF4E with 4E-BP1 is an induced fit to a completely disordered protein. Protein Sci 7:1639\u20131642. https:\/\/doi.org\/10.1002\/pro.5560070720","journal-title":"Protein Sci"},{"key":"5553_CR58","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.1007\/s00018-021-03938-z","volume":"78","author":"A Romagnoli","year":"2021","unstructured":"Romagnoli A, D\u2019Agostino M, Ardiccioni C et al (2021) Control of the eIF4E activity: structural insights and pharmacological implications. Cell Mol Life Sci 78:6869\u20136885. https:\/\/doi.org\/10.1007\/s00018-021-03938-z","journal-title":"Cell Mol Life Sci"},{"key":"5553_CR59","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1038\/s41598-024-54154-1","volume":"14","author":"S Nagaraj","year":"2024","unstructured":"Nagaraj S, Stankiewicz-Drogon A, Darzynkiewicz E et al (2024) Mir-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levels. Sci Rep 14:4237. https:\/\/doi.org\/10.1038\/s41598-024-54154-1","journal-title":"Sci Rep"},{"key":"5553_CR60","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nsb0997-717","volume":"4","author":"H Matsuo","year":"1997","unstructured":"Matsuo H, Li H, McGuire AM et al (1997) Structure of translation factor elF4E bound to m7GDP and interaction with 4E-binding protein. Nat Struct Biol 4:717\u2013724. https:\/\/doi.org\/10.1038\/nsb0997-717","journal-title":"Nat Struct Biol"},{"key":"5553_CR61","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1038\/s41598-017-08204-6","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Huang J, Zheng X et al (2017) Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mTOR\/4E-BP1 signaling pathway. Sci Rep 7:7877. https:\/\/doi.org\/10.1038\/s41598-017-08204-6","journal-title":"Sci Rep"},{"key":"5553_CR62","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1007\/s10787-025-01846-3","volume":"33","author":"K Mahto","year":"2025","unstructured":"Mahto K, Kuwar OK, Maloo A, Kalia N (2025) Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NF\u0138B, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis. Inflammopharmacology 33:5011\u20135021. https:\/\/doi.org\/10.1007\/s10787-025-01846-3","journal-title":"Inflammopharmacology"},{"key":"5553_CR63","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ptr.5298","volume":"29","author":"Y-F Wang","year":"2015","unstructured":"Wang Y-F, Li T, Tang Z-H et al (2015) Baicalein triggers autophagy and inhibits the protein kinase B\/mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells. Phytother Res 29:674\u2013679. https:\/\/doi.org\/10.1002\/ptr.5298","journal-title":"Phytother Res"},{"key":"5553_CR64","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s10787-025-01698-x","volume":"33","author":"OK Kuwar","year":"2025","unstructured":"Kuwar OK, Kalia N (2025) Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NF\u0138B in neurodegenerative disease. Inflammopharmacology 33:1303\u20131310. https:\/\/doi.org\/10.1007\/s10787-025-01698-x","journal-title":"Inflammopharmacology"},{"key":"5553_CR65","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1007\/s10787-025-01839-2","volume":"33","author":"OK Kuwar","year":"2025","unstructured":"Kuwar OK, Singh S (2025) Baicalein-mediated regulation of Nrf2\/ARE, NF\u0138B, and MAPK signaling in Huntington\u2019s disease: a promising strategy against neuroinflammation and neurodegeneration. Inflammopharmacology 33:3789\u20133803. https:\/\/doi.org\/10.1007\/s10787-025-01839-2","journal-title":"Inflammopharmacology"},{"key":"5553_CR66","doi-asserted-by":"publisher","first-page":"2988S","DOI":"10.1093\/jn\/131.11.2988S","volume":"131","author":"M Miron","year":"2001","unstructured":"Miron M, Sonenberg N (2001) Regulation of translation via TOR signaling: insights from Drosophila melanogaster. J Nutr 131:2988S-2993S. https:\/\/doi.org\/10.1093\/jn\/131.11.2988S","journal-title":"J Nutr"},{"key":"5553_CR67","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/35078571","volume":"3","author":"M Miron","year":"2001","unstructured":"Miron M, Verd\u00fa J, Lachance PED et al (2001) The translational inhibitor 4E-BP is an effector of PI(3)K\/Akt signalling and cell growth in Drosophila. Nat Cell Biol 3:596\u2013601. https:\/\/doi.org\/10.1038\/35078571","journal-title":"Nat Cell Biol"},{"key":"5553_CR68","doi-asserted-by":"publisher","first-page":"21167","DOI":"10.1016\/S0021-9258(19)36812-7","volume":"267","author":"S Lanker","year":"1992","unstructured":"Lanker S, M\u00fcller PP, Altmann M et al (1992) Interactions of the eIF-4F subunits in the yeast Saccharomyces cerevisiae. J Biol Chem 267:21167\u201321171. https:\/\/doi.org\/10.1016\/S0021-9258(19)36812-7","journal-title":"J Biol Chem"},{"key":"5553_CR69","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/emboj\/16.5.1114","volume":"16","author":"M Altmann","year":"1997","unstructured":"Altmann M (1997) A novel inhibitor of cap-dependent translation initiation in yeast: p20 competes with eIF4G for binding to eIF4E. EMBO J 16:1114\u20131121. https:\/\/doi.org\/10.1093\/emboj\/16.5.1114","journal-title":"EMBO J"},{"key":"5553_CR70","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1073\/pnas.94.10.5201","volume":"94","author":"J de la Cruz","year":"1997","unstructured":"de la Cruz J, Iost I, Kressler D, Linder P (1997) The p20 and Ded1 proteins have antagonistic roles in eIF4E-dependent translation in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 94:5201\u20135206. https:\/\/doi.org\/10.1073\/pnas.94.10.5201","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5553_CR71","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1006\/viro.1997.8757","volume":"237","author":"A-C Gingras","year":"1997","unstructured":"Gingras A-C, Sonenberg N (1997) Adenovirus infection inactivates the translational inhibitors 4E-BP1 and 4E-BP2. Virology 237:182\u2013186. https:\/\/doi.org\/10.1006\/viro.1997.8757","journal-title":"Virology"},{"key":"5553_CR72","doi-asserted-by":"publisher","unstructured":"Mishra (2009) Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo_00000251","DOI":"10.3892\/ijo_00000251"},{"key":"5553_CR73","doi-asserted-by":"publisher","first-page":"10686","DOI":"10.1128\/JVI.00896-12","volume":"86","author":"M Kobayashi","year":"2012","unstructured":"Kobayashi M, Arias C, Garabedian A et al (2012) Site-specific cleavage of the host poly(A) binding protein by the Encephalomyocarditis virus 3C proteinase stimulates viral replication. J Virol 86:10686\u201310694. https:\/\/doi.org\/10.1128\/JVI.00896-12","journal-title":"J Virol"},{"key":"5553_CR74","doi-asserted-by":"publisher","first-page":"32779","DOI":"10.1074\/jbc.272.52.32779","volume":"272","author":"RGJ Vries","year":"1997","unstructured":"Vries RGJ, Flynn A, Patel JC et al (1997) Heat shock increases the association of binding protein-1 with initiation factor 4E. J Biol Chem 272:32779\u201332784. https:\/\/doi.org\/10.1074\/jbc.272.52.32779","journal-title":"J Biol Chem"},{"key":"5553_CR75","doi-asserted-by":"publisher","first-page":"26850","DOI":"10.1074\/jbc.272.43.26850","volume":"272","author":"GC Scheper","year":"1997","unstructured":"Scheper GC, Mulder J, Kleijn M et al (1997) Inactivation of eIF2B and phosphorylation of PHAS-I in heat-shocked rat hepatoma cells. J Biol Chem 272:26850\u201326856. https:\/\/doi.org\/10.1074\/jbc.272.43.26850","journal-title":"J Biol Chem"},{"key":"5553_CR76","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0022-2836(02)00328-5","volume":"319","author":"A Niedzwiecka","year":"2002","unstructured":"Niedzwiecka A, Marcotrigiano J, Stepinski J et al (2002) Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5\u2032 cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins. J Mol Biol 319:615\u2013635. https:\/\/doi.org\/10.1016\/S0022-2836(02)00328-5","journal-title":"J Mol Biol"},{"key":"5553_CR77","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.str.2013.08.030","volume":"21","author":"S Lukhele","year":"2013","unstructured":"Lukhele S, Bah A, Lin H et al (2013) Interaction of the eukaryotic initiation factor 4E with 4E-BP2 at a dynamic bipartite interface. Structure 21:2186\u20132196. https:\/\/doi.org\/10.1016\/j.str.2013.08.030","journal-title":"Structure"},{"key":"5553_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112892","volume":"42","author":"Y Dong","year":"2023","unstructured":"Dong Y, Srour O, Lukhovitskaya N et al (2023) Functional analogs of mammalian 4E-BPs reveal a role for TOR in global plant translation. Cell Rep 42:112892. https:\/\/doi.org\/10.1016\/j.celrep.2023.112892","journal-title":"Cell Rep"},{"key":"5553_CR79","doi-asserted-by":"publisher","first-page":"62a","DOI":"10.1016\/j.bpj.2022.11.544","volume":"122","author":"TE Tsangaris","year":"2023","unstructured":"Tsangaris TE, Smyth S, Gomes GW et al (2023) Beyond disorder: an integrative investigation of the intrinsically disordered protein 4E-BP2. Biophys J 122:62a. https:\/\/doi.org\/10.1016\/j.bpj.2022.11.544","journal-title":"Biophys J"},{"key":"5553_CR80","doi-asserted-by":"publisher","DOI":"10.1101\/lm.054018.124","volume":"31","author":"Z Huang","year":"2024","unstructured":"Huang Z, Wiebe S, Nagpal A et al (2024) Dysregulating mTORC1-4E-BP2 signaling in GABAergic interneurons impairs hippocampus-dependent learning and memory. Learn Mem 31:a054018. https:\/\/doi.org\/10.1101\/lm.054018.124","journal-title":"Learn Mem"},{"key":"5553_CR81","doi-asserted-by":"publisher","unstructured":"Abraham RT (2016) 4E-BP2 hardwires lymphocytes for rapamycin sensitivity. Sci Signal 9. https:\/\/doi.org\/10.1126\/scisignal.aaf8190","DOI":"10.1126\/scisignal.aaf8190"},{"key":"5553_CR82","doi-asserted-by":"publisher","first-page":"215a","DOI":"10.1016\/j.bpj.2020.11.1449","volume":"120","author":"S Smyth","year":"2021","unstructured":"Smyth S, Tsangaris T, Bah A et al (2021) Modelling the multifarious conformations of the intrinsically disordered protein 4E-BP2 with sm-FRET, SAXS & PRE restraints. Biophys J 120:215a. https:\/\/doi.org\/10.1016\/j.bpj.2020.11.1449","journal-title":"Biophys J"},{"key":"5553_CR83","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/febs.16275","volume":"290","author":"M Christie","year":"2023","unstructured":"Christie M, Igreja C (2023) eIF4E-homologous protein (4EHP): a multifarious cap-binding protein. FEBS J 290:266\u2013285. https:\/\/doi.org\/10.1111\/febs.16275","journal-title":"FEBS J"},{"key":"5553_CR84","doi-asserted-by":"publisher","first-page":"8a","DOI":"10.1016\/j.bpj.2022.11.275","volume":"122","author":"S Smyth","year":"2023","unstructured":"Smyth S, Gradinaru CC, Forman-Kay JD (2023) Multimodal interactions between a disordered protein and its folded target at single-molecule level. Biophys J 122:8a. https:\/\/doi.org\/10.1016\/j.bpj.2022.11.275","journal-title":"Biophys J"},{"key":"5553_CR85","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1039\/D3CP05736D","volume":"26","author":"J Zeng","year":"2024","unstructured":"Zeng J, Lu C, Huang X, Li Y (2024) The human eIF4E:4E-BP2 complex structure for studying hyperphosphorylation. Phys Chem Chem Phys 26:10660\u201310672. https:\/\/doi.org\/10.1039\/D3CP05736D","journal-title":"Phys Chem Chem Phys"},{"key":"5553_CR86","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1021\/acs.jctc.6b00848","volume":"13","author":"J Zeng","year":"2017","unstructured":"Zeng J, Jiang F, Wu Y-D (2017) Mechanism of phosphorylation-induced folding of 4E-BP2 revealed by molecular dynamics simulations. J Chem Theory Comput 13:320\u2013328. https:\/\/doi.org\/10.1021\/acs.jctc.6b00848","journal-title":"J Chem Theory Comput"},{"key":"5553_CR87","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.bpj.2022.07.015","volume":"121","author":"S Smyth","year":"2022","unstructured":"Smyth S, Zhang Z, Bah A et al (2022) Multisite phosphorylation and binding alter conformational dynamics of the 4E-BP2 protein. Biophys J 121:3049\u20133060. https:\/\/doi.org\/10.1016\/j.bpj.2022.07.015","journal-title":"Biophys J"},{"key":"5553_CR88","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1039\/C9CP05888E","volume":"22","author":"K Wang","year":"2020","unstructured":"Wang K, Ning S, Guo Y et al (2020) The regulation mechanism of phosphorylation and mutations in intrinsically disordered protein 4E-BP2. Phys Chem Chem Phys 22:2938\u20132948. https:\/\/doi.org\/10.1039\/C9CP05888E","journal-title":"Phys Chem Chem Phys"},{"key":"5553_CR89","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nlm.2006.08.012","volume":"87","author":"JL Banko","year":"2007","unstructured":"Banko JL, Merhav M, Stern E et al (2007) Behavioral alterations in mice lacking the translation repressor 4E-BP2. Neurobiol Learn Mem 87:248\u2013256. https:\/\/doi.org\/10.1016\/j.nlm.2006.08.012","journal-title":"Neurobiol Learn Mem"},{"key":"5553_CR90","doi-asserted-by":"publisher","unstructured":"Olson KE, Booth GC, Poulin F, et al (2009) Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E\u2010BP1 and 4E\u2010BP2. Immunology 128. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02981.x","DOI":"10.1111\/j.1365-2567.2008.02981.x"},{"key":"5553_CR91","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1523\/JNEUROSCI.3264-12.2013","volume":"33","author":"I Ran","year":"2013","unstructured":"Ran I, Gkogkas CG, Vasuta C et al (2013) Selective regulation of GluA subunit synthesis and AMPA receptor-mediated synaptic function and plasticity by the translation repressor 4E-BP2 in hippocampal pyramidal cells. J Neurosci 33:1872\u20131886. https:\/\/doi.org\/10.1523\/JNEUROSCI.3264-12.2013","journal-title":"J Neurosci"},{"key":"5553_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz210","author":"CC Areal","year":"2019","unstructured":"Areal CC, Cao R, Sonenberg N, Mongrain V (2019) Wakefulness\/sleep architecture and electroencephalographic activity in mice lacking the translational repressor 4E-BP1 or 4E-BP2. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsz210","journal-title":"Sleep"},{"key":"5553_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109036","volume":"35","author":"M Hooshmandi","year":"2021","unstructured":"Hooshmandi M, Truong VT, Fields E et al (2021) 4E-BP2-dependent translation in cerebellar Purkinje cells controls spatial memory but not autism-like behaviors. Cell Rep 35:109036. https:\/\/doi.org\/10.1016\/j.celrep.2021.109036","journal-title":"Cell Rep"},{"key":"5553_CR94","doi-asserted-by":"publisher","first-page":"18060","DOI":"10.1073\/pnas.1908126116","volume":"116","author":"S Wiebe","year":"2019","unstructured":"Wiebe S, Nagpal A, Truong VT et al (2019) Inhibitory interneurons mediate autism-associated behaviors via 4E-BP2. Proc Natl Acad Sci U S A 116:18060\u201318067. https:\/\/doi.org\/10.1073\/pnas.1908126116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5553_CR95","doi-asserted-by":"publisher","first-page":"7472","DOI":"10.1021\/acs.jpcb.3c04052","volume":"127","author":"TE Tsangaris","year":"2023","unstructured":"Tsangaris TE, Smyth S, Gomes G-NW et al (2023) Delineating structural propensities of the 4E-BP2 protein via integrative modeling and clustering. J Phys Chem B 127:7472\u20137486. https:\/\/doi.org\/10.1021\/acs.jpcb.3c04052","journal-title":"J Phys Chem B"},{"key":"5553_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212268","volume":"25","author":"D Joseph","year":"2024","unstructured":"Joseph D (2024) The fundamental neurobiological mechanism of oxidative stress-related 4E-BP2 protein deamidation. Int J Mol Sci 25:12268. https:\/\/doi.org\/10.3390\/ijms252212268","journal-title":"Int J Mol Sci"},{"key":"5553_CR97","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2010.02.022","volume":"37","author":"M Bidinosti","year":"2010","unstructured":"Bidinosti M, Ran I, Sanchez-Carbente MR et al (2010) Postnatal deamidation of 4E-BP2 in brain enhances its association with Raptor and alters kinetics of excitatory synaptic transmission. Mol Cell 37:797\u2013808. https:\/\/doi.org\/10.1016\/j.molcel.2010.02.022","journal-title":"Mol Cell"},{"key":"5553_CR98","doi-asserted-by":"publisher","first-page":"19402","DOI":"10.1074\/jbc.M110.120774","volume":"285","author":"M Bidinosti","year":"2010","unstructured":"Bidinosti M, Martineau Y, Frank F, Sonenberg N (2010) Repair of isoaspartate formation modulates the interaction of deamidated 4E-BP2 with mTORC1 in brain. J Biol Chem 285:19402\u201319408. https:\/\/doi.org\/10.1074\/jbc.M110.120774","journal-title":"J Biol Chem"},{"key":"5553_CR99","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1016\/j.celrep.2019.11.023","volume":"29","author":"S Kouloulia","year":"2019","unstructured":"Kouloulia S, Hallin EI, Simbriger K et al (2019) Raptor-mediated proteasomal degradation of deamidated 4E-BP2 regulates postnatal neuronal translation and NF-\u03baB activity. Cell Rep 29:3620-3635.e7. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.023","journal-title":"Cell Rep"},{"key":"5553_CR100","doi-asserted-by":"publisher","first-page":"10327","DOI":"10.3390\/ijms221910327","volume":"22","author":"E Mart\u00ednez-Alonso","year":"2021","unstructured":"Mart\u00ednez-Alonso E, Guerra-P\u00e9rez N, Escobar-Peso A et al (2021) Differential association of 4E-BP2-interacting proteins is related to selective delayed neuronal death after ischemia. Int J Mol Sci 22:10327. https:\/\/doi.org\/10.3390\/ijms221910327","journal-title":"Int J Mol Sci"},{"key":"5553_CR101","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/jcbfm.2013.60","volume":"33","author":"MI Ayuso","year":"2013","unstructured":"Ayuso MI, Mart\u00ednez-Alonso E, Cid C et al (2013) The translational repressor eIF4E-binding protein 2 (4E-BP2) correlates with selective delayed neuronal death after ischemia. J Cereb Blood Flow Metab 33:1173\u20131181. https:\/\/doi.org\/10.1038\/jcbfm.2013.60","journal-title":"J Cereb Blood Flow Metab"},{"key":"5553_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121958","volume":"10","author":"MI Ayuso","year":"2015","unstructured":"Ayuso MI, Martinez-Alonso E, Salvador N et al (2015) Dissociation of eIF4E-binding protein 2 (4E-BP2) from eIF4E independent of Thr37\/Thr46 phosphorylation in the ischemic stress response. PLoS ONE 10:e0121958. https:\/\/doi.org\/10.1371\/journal.pone.0121958","journal-title":"PLoS ONE"},{"key":"5553_CR103","doi-asserted-by":"publisher","first-page":"8246","DOI":"10.3390\/ijms24098246","volume":"24","author":"E Mart\u00ednez-Alonso","year":"2023","unstructured":"Mart\u00ednez-Alonso E, Escobar-Peso A, Guerra-P\u00e9rez N et al (2023) Dihydropyrimidinase-related protein 2 is a new partner in the binding between 4E-BP2 and eIF4E related to neuronal death after cerebral ischemia. Int J Mol Sci 24:8246. https:\/\/doi.org\/10.3390\/ijms24098246","journal-title":"Int J Mol Sci"},{"key":"5553_CR104","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.celrep.2013.09.017","volume":"5","author":"NW Hartman","year":"2013","unstructured":"Hartman NW, Lin TV, Zhang L et al (2013) mTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1\/2, to regulate neural stem cell self-renewal in vivo. Cell Rep 5:433\u2013444. https:\/\/doi.org\/10.1016\/j.celrep.2013.09.017","journal-title":"Cell Rep"},{"key":"5553_CR105","doi-asserted-by":"publisher","first-page":"52290","DOI":"10.1074\/jbc.M310761200","volume":"278","author":"F Poulin","year":"2003","unstructured":"Poulin F, Brueschke A, Sonenberg N (2003) Gene fusion and overlapping reading frames in the mammalian genes for 4E-BP3 and MASK. J Biol Chem 278:52290\u201352297. https:\/\/doi.org\/10.1074\/jbc.M310761200","journal-title":"J Biol Chem"},{"key":"5553_CR106","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1128\/MCB.22.6.1674-1683.2002","volume":"22","author":"AR Tee","year":"2002","unstructured":"Tee AR, Proud CG (2002) Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol Cell Biol 22:1674\u20131683. https:\/\/doi.org\/10.1128\/MCB.22.6.1674-1683.2002","journal-title":"Mol Cell Biol"},{"key":"5553_CR107","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbrc.2007.01.198","volume":"355","author":"F Abiko","year":"2007","unstructured":"Abiko F, Tomoo K, Mizuno A et al (2007) Binding preference of eIF4E for 4E-binding protein isoform and function of eIF4E N-terminal flexible region for interaction, studied by SPR analysis. Biochem Biophys Res Commun 355:667\u2013672. https:\/\/doi.org\/10.1016\/j.bbrc.2007.01.198","journal-title":"Biochem Biophys Res Commun"},{"key":"5553_CR108","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00395-024-01089-3","volume":"120","author":"S Li","year":"2024","unstructured":"Li S, Tajiri K, Yuan Z et al (2024) 4E-BP3 deficiency impairs dendritic cell activation and CD4+ T cell differentiation and attenuates \u03b1-myosin-specific T cell-mediated myocarditis in mice. Basic Res Cardiol 120:225\u2013240. https:\/\/doi.org\/10.1007\/s00395-024-01089-3","journal-title":"Basic Res Cardiol"},{"key":"5553_CR109","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.febslet.2012.05.059","volume":"586","author":"C-C Chen","year":"2012","unstructured":"Chen C-C, Lee J-C, Chang M-C (2012) 4E-BP3 regulates eIF4E-mediated nuclear mRNA export and interacts with replication protein A2. FEBS Lett 586:2260\u20132266. https:\/\/doi.org\/10.1016\/j.febslet.2012.05.059","journal-title":"FEBS Lett"},{"key":"5553_CR110","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","volume":"26","author":"Y Xu","year":"2014","unstructured":"Xu Y, Liu C, Chen S et al (2014) Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson\u2019s disease. Cell Signal 26:1680\u20131689. https:\/\/doi.org\/10.1016\/j.cellsig.2014.04.009","journal-title":"Cell Signal"},{"key":"5553_CR111","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/cdd.2011.119","volume":"19","author":"TL Ng","year":"2012","unstructured":"Ng TL, Leprivier G, Robertson MD et al (2012) The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death Differ 19:501\u2013510. https:\/\/doi.org\/10.1038\/cdd.2011.119","journal-title":"Cell Death Differ"},{"key":"5553_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.668500","author":"Y-J Liu","year":"2021","unstructured":"Liu Y-J, Chern Y (2021) Contribution of energy dysfunction to impaired protein translation in neurodegenerative diseases. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2021.668500","journal-title":"Front Cell Neurosci"},{"key":"5553_CR113","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yjmcc.2019.02.006","volume":"129","author":"DN Meijles","year":"2019","unstructured":"Meijles DN, Zoumpoulidou G, Markou T et al (2019) The cardiomyocyte \u201credox rheostat\u201d: Redox signalling via the AMPK-mTOR axis and regulation of gene and protein expression balancing survival and death. J Mol Cell Cardiol 129:118\u2013129. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.02.006","journal-title":"J Mol Cell Cardiol"},{"key":"5553_CR114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317846121","author":"YS Kim","year":"2024","unstructured":"Kim YS, Kimball SR, Piskounova E et al (2024) Stress response regulation of mRNA translation: implications for antioxidant enzyme expression in cancer. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2317846121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5553_CR115","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neuron.2013.06.026","volume":"79","author":"R Cao","year":"2013","unstructured":"Cao R, Robinson B, Xu H et al (2013) Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR\/4E-BP1 signaling. Neuron 79:712\u2013724. https:\/\/doi.org\/10.1016\/j.neuron.2013.06.026","journal-title":"Neuron"},{"key":"5553_CR116","doi-asserted-by":"publisher","first-page":"48","DOI":"10.18632\/aging.100633","volume":"6","author":"RV Khapre","year":"2014","unstructured":"Khapre RV, Kondratova AA, Patel S et al (2014) BMAL1-dependent regulation of the mTOR signaling pathway delays aging. Aging 6:48\u201357. https:\/\/doi.org\/10.18632\/aging.100633","journal-title":"Aging"},{"key":"5553_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00367","author":"R Cao","year":"2018","unstructured":"Cao R (2018) mTOR signaling, translational control, and the circadian clock. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2018.00367","journal-title":"Front Genet"},{"key":"5553_CR118","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.162771","author":"MF Kanan","year":"2024","unstructured":"Kanan MF, Sheehan PW, Haines JN et al (2024) Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.162771","journal-title":"JCI Insight"},{"key":"5553_CR119","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148288","author":"CS Colwell","year":"2021","unstructured":"Colwell CS (2021) Defining circadian disruption in neurodegenerative disorders. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI148288","journal-title":"J Clin Invest"},{"key":"5553_CR120","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/jnc.15883","volume":"168","author":"JB Canever","year":"2024","unstructured":"Canever JB, Queiroz LY, Soares ES et al (2024) Circadian rhythm alterations affecting the pathology of neurodegenerative diseases. J Neurochem 168:1475\u20131489. https:\/\/doi.org\/10.1111\/jnc.15883","journal-title":"J Neurochem"},{"key":"5553_CR121","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1152\/ajpendo.00457.2003","volume":"287","author":"Z Liu","year":"2004","unstructured":"Liu Z, Li G, Kimball SR et al (2004) Glucocorticoids modulate amino acid-induced translation initiation in human skeletal muscle. Am J Physiol-Endocrinol Metab 287:E275\u2013E281. https:\/\/doi.org\/10.1152\/ajpendo.00457.2003","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"5553_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1535-z","volume":"15","author":"L Gu","year":"2015","unstructured":"Gu L, Xie L, Zuo C et al (2015) Targeting mTOR\/p70S6K\/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt lymphoma. BMC Cancer 15:529. https:\/\/doi.org\/10.1186\/s12885-015-1535-z","journal-title":"BMC Cancer"},{"key":"5553_CR123","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1073\/pnas.1605740113","volume":"113","author":"TV Lin","year":"2016","unstructured":"Lin TV, Hsieh L, Kimura T et al (2016) Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration. Proc Natl Acad Sci U S A 113:11330\u201311335. https:\/\/doi.org\/10.1073\/pnas.1605740113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5553_CR124","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/npp.2015.171","volume":"41","author":"BS McEwen","year":"2016","unstructured":"McEwen BS, Nasca C, Gray JD (2016) Stress effects on neuronal structure: hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology 41:3\u201323. https:\/\/doi.org\/10.1038\/npp.2015.171","journal-title":"Neuropsychopharmacology"},{"key":"5553_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/alz.059761","author":"FC Ribeiro","year":"2022","unstructured":"Ribeiro FC, Ferreira DC, De Felice FG et al (2022) Attenuation of translational repression rescues memory impairment in Alzheimer`s disease mice. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.059761","journal-title":"Alzheimers Dement"},{"key":"5553_CR126","doi-asserted-by":"crossref","unstructured":"Ribeiro FC, Cozachenco D, Lacaille J-C, et al (2024) Genetic reduction of the translational repressors FMRP and 4E-BP2 preserves memory in mouse models of Alzheimer\u2019s disease","DOI":"10.1101\/2024.10.08.617315"},{"key":"5553_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","volume":"72","author":"M Zv\u011b\u0159ov\u00e1","year":"2019","unstructured":"Zv\u011b\u0159ov\u00e1 M (2019) Clinical aspects of Alzheimer\u2019s disease. Clin Biochem 72:3\u20136. https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.04.015","journal-title":"Clin Biochem"},{"key":"5553_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/alz.087688","author":"S Bermudez","year":"2024","unstructured":"Bermudez S, Choi J, Kim S et al (2024) The mTOR-4E-BP1 axis controls microglia inflammatory and neurodegenerative responses. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.087688","journal-title":"Alzheimers Dement"},{"key":"5553_CR129","doi-asserted-by":"crossref","unstructured":"Bermudez S, Choi J-H, Vogel JW, et al (2024) Translational control of microglial inflammatory and neurodegenerative responses","DOI":"10.1101\/2024.04.06.587750"},{"key":"5553_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/alz.074211","author":"D Cozachenco","year":"2023","unstructured":"Cozachenco D, Ribeiro FC, Argyrousi EK et al (2023) Correction of mTORC1-mediated brain protein synthesis rescues memory in mouse models of Alzheimer\u2019s disease. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.074211","journal-title":"Alzheimers Dement"},{"key":"5553_CR131","doi-asserted-by":"publisher","unstructured":"Davoody S, Asgari Taei A, Khodabakhsh P, Dargahi L (2024) <scp>mTOR<\/scp> signaling and Alzheimer\u2019s disease: What we know and where we are? CNS Neurosci Ther 30. https:\/\/doi.org\/10.1111\/cns.14463","DOI":"10.1111\/cns.14463"},{"key":"5553_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105311","volume":"155","author":"D Rapaka","year":"2022","unstructured":"Rapaka D, Bitra VR, Challa SR, Adiukwu PC (2022) mTOR signaling as a molecular target for the alleviation of Alzheimer\u2019s disease pathogenesis. Neurochem Int 155:105311. https:\/\/doi.org\/10.1016\/j.neuint.2022.105311","journal-title":"Neurochem Int"},{"key":"5553_CR133","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25:5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"key":"5553_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1478199","author":"X Chen","year":"2025","unstructured":"Chen X, Tian Q, Gao M et al (2025) Lingguizhugan decoction enhances autophagy of Alzheimer\u2019s disease via regulating the mTOR\/ p70s6K pathway in vivo and in vitro. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2025.1478199","journal-title":"Front Aging Neurosci"},{"key":"5553_CR135","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1111\/cns.14133","volume":"29","author":"G Jiang","year":"2023","unstructured":"Jiang G, Long Z, Wang Y et al (2023) Inhibition of mammalian target of rapamycin complex 1 in the brain microvascular endothelium ameliorates diabetic A\u03b2 brain deposition and cognitive impairment via the sterol-regulatory element-binding protein 1\/lipoprotein receptor-associated protein 1 signaling pathway. CNS Neurosci Ther 29:1762\u20131775. https:\/\/doi.org\/10.1111\/cns.14133","journal-title":"CNS Neurosci Ther"},{"key":"5553_CR136","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nbd.2007.09.008","volume":"29","author":"M Damjanac","year":"2008","unstructured":"Damjanac M, Rioux Bilan A, Paccalin M et al (2008) Dissociation of Akt\/PKB and ribosomal S6 kinase signaling markers in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis 29:354\u2013367. https:\/\/doi.org\/10.1016\/j.nbd.2007.09.008","journal-title":"Neurobiol Dis"},{"key":"5553_CR137","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1111\/j.1742-4658.2005.04833.x","volume":"272","author":"X Li","year":"2005","unstructured":"Li X, Alafuzoff I, Soininen H et al (2005) Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer\u2019s disease brain. FEBS J 272:4211\u20134220. https:\/\/doi.org\/10.1111\/j.1742-4658.2005.04833.x","journal-title":"FEBS J"},{"key":"5553_CR138","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/jnc.13037","volume":"133","author":"A Tramutola","year":"2015","unstructured":"Tramutola A, Triplett JC, Di Domenico F et al (2015) Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. J Neurochem 133:739\u2013749. https:\/\/doi.org\/10.1111\/jnc.13037","journal-title":"J Neurochem"},{"key":"5553_CR139","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1515\/tnsci-2016-0022","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Li G-J, Hu H-X et al (2016) Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer\u2019s disease rats. Transl Neurosci 7:151\u2013157. https:\/\/doi.org\/10.1515\/tnsci-2016-0022","journal-title":"Transl Neurosci"},{"key":"5553_CR140","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3233\/JAD-220307","volume":"90","author":"Y-H Yang","year":"2022","unstructured":"Yang Y-H, Hsieh S-W, Chang H-W et al (2022) Gamma frequency inhibits the secretion and aggregation of amyloid-\u03b2 and decreases the phosphorylation of mTOR and tau proteins in vitro. J Alzheimers Dis 90:917\u2013928. https:\/\/doi.org\/10.3233\/JAD-220307","journal-title":"J Alzheimers Dis"},{"key":"5553_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1366061","author":"P-L Xie","year":"2024","unstructured":"Xie P-L, Zheng M-Y, Han R et al (2024) Pharmacological mTOR inhibitors in ameliorating Alzheimer\u2019s disease: current review and perspectives. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1366061","journal-title":"Front Pharmacol"},{"key":"5553_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-022-00396-x","volume":"9","author":"M-Z Li","year":"2022","unstructured":"Li M-Z, Liu E-J, Zhou Q-Z et al (2022) Intracellular accumulation of tau inhibits autophagosome formation by activating TIA1-amino acid-mTORC1 signaling. Mil Med Res 9:38. https:\/\/doi.org\/10.1186\/s40779-022-00396-x","journal-title":"Mil Med Res"},{"key":"5553_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.01017","author":"Z Mueed","year":"2019","unstructured":"Mueed Z, Tandon P, Maurya SK et al (2019) Tau and mTOR: the hotspots for multifarious diseases in Alzheimer\u2019s development. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2018.01017","journal-title":"Front Neurosci"},{"key":"5553_CR144","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/acel.12057","volume":"12","author":"A Caccamo","year":"2013","unstructured":"Caccamo A, Magr\u00ec A, Medina DX et al (2013) <scp>mTOR<\/scp> regulates tau phosphorylation and degradation: implications for Alzheimer\u2019s disease and other tauopathies. Aging Cell 12:370\u2013380. https:\/\/doi.org\/10.1111\/acel.12057","journal-title":"Aging Cell"},{"key":"5553_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094143","volume":"26","author":"D Joseph","year":"2025","unstructured":"Joseph D (2025) The unified theory of neurodegeneration pathogenesis based on axon deamidation. Int J Mol Sci 26:4143. https:\/\/doi.org\/10.3390\/ijms26094143","journal-title":"Int J Mol Sci"},{"key":"5553_CR146","doi-asserted-by":"publisher","unstructured":"(2022) Impact of sleep on autophagy and neurodegenerative disease: sleeping your mind clear. Archives Mol Biol Genetics 1. https:\/\/doi.org\/10.33696\/genetics.1.007","DOI":"10.33696\/genetics.1.007"},{"key":"5553_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062762","volume":"26","author":"Y Li","year":"2025","unstructured":"Li Y, Shi R, Xia L et al (2025) Identification of key active constituents in Eucommia ulmoides Oliv. leaves against Parkinson\u2019s disease and the alleviative effects via 4E-BP1 up-regulation. Int J Mol Sci 26:2762. https:\/\/doi.org\/10.3390\/ijms26062762","journal-title":"Int J Mol Sci"},{"key":"5553_CR148","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"5553_CR149","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a008888\u2013a008888. https:\/\/doi.org\/10.1101\/cshperspect.a008888","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5553_CR150","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/emboj.2008.163","volume":"27","author":"Y Imai","year":"2008","unstructured":"Imai Y, Gehrke S, Wang H-Q et al (2008) Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 27:2432\u20132443. https:\/\/doi.org\/10.1038\/emboj.2008.163","journal-title":"EMBO J"},{"key":"5553_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10863-022-09952-5","volume":"55","author":"DF Gon\u00e7alves","year":"2023","unstructured":"Gon\u00e7alves DF, Senger LR, Foletto JVP et al (2023) Caffeine improves mitochondrial function in PINK1B9-null mutant Drosophila melanogaster. J Bioenerg Biomembr 55:1\u201313. https:\/\/doi.org\/10.1007\/s10863-022-09952-5","journal-title":"J Bioenerg Biomembr"},{"key":"5553_CR152","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1128\/MCB.05207-11","volume":"31","author":"N Saini","year":"2011","unstructured":"Saini N, Georgiev O, Schaffner W (2011) The parkin mutant phenotype in the fly is largely rescued by metal-responsive transcription factor (MTF-1). Mol Cell Biol 31:2151\u20132161. https:\/\/doi.org\/10.1128\/MCB.05207-11","journal-title":"Mol Cell Biol"},{"key":"5553_CR153","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nn.2372","volume":"12","author":"LS Tain","year":"2009","unstructured":"Tain LS, Mortiboys H, Tao RN et al (2009) Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 12:1129\u20131135. https:\/\/doi.org\/10.1038\/nn.2372","journal-title":"Nat Neurosci"},{"key":"5553_CR154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001237","volume":"6","author":"S Liu","year":"2010","unstructured":"Liu S, Lu B (2010) Reduction of protein translation and activation of autophagy protect against PINK1 pathogenesis in Drosophila melanogaster. PLoS Genet 6:e1001237. https:\/\/doi.org\/10.1371\/journal.pgen.1001237","journal-title":"PLoS Genet"},{"key":"5553_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008730","volume":"5","author":"A Kumar","year":"2010","unstructured":"Kumar A, Greggio E, Beilina A et al (2010) The Parkinson\u2019s disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS ONE 5:e8730. https:\/\/doi.org\/10.1371\/journal.pone.0008730","journal-title":"PLoS ONE"},{"key":"5553_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047784","volume":"7","author":"A Trancikova","year":"2012","unstructured":"Trancikova A, Mamais A, Webber PJ et al (2012) Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations. PLoS ONE 7:e47784. https:\/\/doi.org\/10.1371\/journal.pone.0047784","journal-title":"PLoS ONE"},{"key":"5553_CR157","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1523\/JNEUROSCI.2286-13.2014","volume":"34","author":"W Lin","year":"2014","unstructured":"Lin W, Wadlington NL, Chen L et al (2014) Loss of PINK1 attenuates HIF-1\u03b1 induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia. J Neurosci 34:3079\u20133089. https:\/\/doi.org\/10.1523\/JNEUROSCI.2286-13.2014","journal-title":"J Neurosci"},{"key":"5553_CR158","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.21037\/apm-20-1096","volume":"10","author":"G Zhang","year":"2021","unstructured":"Zhang G, Yin L, Luo Z et al (2021) Effects and potential mechanisms of rapamycin on MPTP-induced acute Parkinson\u2019s disease in mice. Ann Palliat Med 10:2889\u20132897. https:\/\/doi.org\/10.21037\/apm-20-1096","journal-title":"Ann Palliat Med"},{"key":"5553_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.719885","author":"S Yang","year":"2021","unstructured":"Yang S, Wan Y, Wu N et al (2021) L-3,4-dihydroxyphenylalanine recovers circadian rhythm disturbances in the rat models of Parkinson\u2019s disease by regulating the D1R-ERK1\/2-mTOR pathway. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2021.719885","journal-title":"Front Aging Neurosci"},{"key":"5553_CR160","doi-asserted-by":"publisher","first-page":"8734","DOI":"10.1523\/JNEUROSCI.0940-20.2020","volume":"40","author":"SG Dastidar","year":"2020","unstructured":"Dastidar SG, Pham MT, Mitchell MB et al (2020) 4E-BP1 protects neurons from misfolded protein stress and Parkinson\u2019s disease toxicity by inducing the mitochondrial unfolded protein response. J Neurosci 40:8734\u20138745. https:\/\/doi.org\/10.1523\/JNEUROSCI.0940-20.2020","journal-title":"J Neurosci"},{"key":"5553_CR161","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add0499","author":"MR Khan","year":"2023","unstructured":"Khan MR, Yin X, Kang S-U et al (2023) Enhanced mTORC1 signaling and protein synthesis in pathologic \u03b1-synuclein cellular and animal models of Parkinson\u2019s disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.add0499","journal-title":"Sci Transl Med"},{"key":"5553_CR162","doi-asserted-by":"crossref","unstructured":"D\u2019Mello SR (2025) Autism spectrum disorder: The cerebellum, genes, and pathways","DOI":"10.20944\/preprints202507.0790.v1"},{"key":"5553_CR163","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/10731911231173089","volume":"31","author":"Y Yu","year":"2024","unstructured":"Yu Y, Ozonoff S, Miller M (2024) Assessment of autism spectrum disorder. Assessment 31:24\u201341. https:\/\/doi.org\/10.1177\/10731911231173089","journal-title":"Assessment"},{"key":"5553_CR164","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/jama.2017.12141","volume":"318","author":"S Sandin","year":"2017","unstructured":"Sandin S, Lichtenstein P, Kuja-Halkola R et al (2017) The heritability of autism spectrum disorder. JAMA 318:1182. https:\/\/doi.org\/10.1001\/jama.2017.12141","journal-title":"JAMA"},{"key":"5553_CR165","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3390\/molecules28041889","volume":"28","author":"SD Thomas","year":"2023","unstructured":"Thomas SD, Jha NK, Ojha S, Sadek B (2023) mTOR signaling disruption and its association with the development of autism spectrum disorder. Molecules 28:1889. https:\/\/doi.org\/10.3390\/molecules28041889","journal-title":"Molecules"},{"key":"5553_CR166","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bpsgos.2021.08.005","volume":"2","author":"A Sato","year":"2022","unstructured":"Sato A, Ikeda K (2022) Genetic and environmental contributions to autism spectrum disorder through mechanistic target of rapamycin. Biol Psychiatry Glob Open Sci 2:95\u2013105. https:\/\/doi.org\/10.1016\/j.bpsgos.2021.08.005","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"5553_CR167","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature11628","volume":"493","author":"CG Gkogkas","year":"2013","unstructured":"Gkogkas CG, Khoutorsky A, Ran I et al (2013) Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 493:371\u2013377. https:\/\/doi.org\/10.1038\/nature11628","journal-title":"Nature"},{"key":"5553_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-015-0184-4","volume":"3","author":"C Nicolini","year":"2015","unstructured":"Nicolini C, Ahn Y, Michalski B et al (2015) Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol Commun 3:3. https:\/\/doi.org\/10.1186\/s40478-015-0184-4","journal-title":"Acta Neuropathol Commun"},{"key":"5553_CR169","doi-asserted-by":"publisher","unstructured":"Bozzi Y, Casarosa S, Caleo M (2012) Epilepsy as a neurodevelopmental disorder. Front Psychiatry 3. https:\/\/doi.org\/10.3389\/fpsyt.2012.00019","DOI":"10.3389\/fpsyt.2012.00019"},{"key":"5553_CR170","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","volume":"51","author":"AT Berg","year":"2010","unstructured":"Berg AT, Berkovic SF, Brodie MJ et al (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005\u20132009. Epilepsia 51:676\u2013685. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02522.x","journal-title":"Epilepsia"},{"key":"5553_CR171","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41573-024-00981-w","volume":"23","author":"P Klein","year":"2024","unstructured":"Klein P, Kaminski RM, Koepp M, L\u00f6scher W (2024) New epilepsy therapies in development. Nat Rev Drug Discov 23:682\u2013708. https:\/\/doi.org\/10.1038\/s41573-024-00981-w","journal-title":"Nat Rev Drug Discov"},{"key":"5553_CR172","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(23)01048-6","volume":"402","author":"AA Asadi-Pooya","year":"2023","unstructured":"Asadi-Pooya AA, Brigo F, Lattanzi S, Blumcke I (2023) Adult epilepsy. Lancet 402:412\u2013424. https:\/\/doi.org\/10.1016\/S0140-6736(23)01048-6","journal-title":"Lancet"},{"key":"5553_CR173","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S1474-4422(23)00151-5","volume":"22","author":"E Perucca","year":"2023","unstructured":"Perucca E, Perucca P, White HS, Wirrell EC (2023) Drug resistance in epilepsy. Lancet Neurol 22:723\u2013734. https:\/\/doi.org\/10.1016\/S1474-4422(23)00151-5","journal-title":"Lancet Neurol"},{"key":"5553_CR174","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.amjmed.2021.01.038","volume":"134","author":"TA Milligan","year":"2021","unstructured":"Milligan TA (2021) Epilepsy: a clinical overview. Am J Med 134:840\u2013847. https:\/\/doi.org\/10.1016\/j.amjmed.2021.01.038","journal-title":"Am J Med"},{"key":"5553_CR175","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1750-3639.2009.00268.x","volume":"20","author":"K Boer","year":"2010","unstructured":"Boer K, Troost D, Timmermans W et al (2010) Pi3k-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors. Brain Pathol 20:234\u2013244. https:\/\/doi.org\/10.1111\/j.1750-3639.2009.00268.x","journal-title":"Brain Pathol"},{"key":"5553_CR176","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.eplepsyres.2016.08.028","volume":"127","author":"A Kakkar","year":"2016","unstructured":"Kakkar A, Majumdar A, Kumar A et al (2016) Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs). Epilepsy Res 127:141\u2013151. https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.08.028","journal-title":"Epilepsy Res"},{"key":"5553_CR177","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1089\/jmf.2016.3712","volume":"19","author":"SR Kim","year":"2016","unstructured":"Kim SR (2016) Control of granule cell dispersion by natural materials such as eugenol and naringin: a potential therapeutic strategy against temporal lobe epilepsy. J Med Food 19:730\u2013736. https:\/\/doi.org\/10.1089\/jmf.2016.3712","journal-title":"J Med Food"},{"key":"5553_CR178","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1172\/JCI127032","volume":"129","author":"JK Kim","year":"2019","unstructured":"Kim JK, Cho J, Kim SH et al (2019) Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy. J Clin Invest 129:4207\u20134223. https:\/\/doi.org\/10.1172\/JCI127032","journal-title":"J Clin Invest"},{"key":"5553_CR179","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025522118","author":"V Sharma","year":"2021","unstructured":"Sharma V, Sood R, Lou D et al (2021) 4E-BP2\u2013dependent translation in parvalbumin neurons controls epileptic seizure threshold. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2025522118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5553_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1257056","author":"LH Nguyen","year":"2023","unstructured":"Nguyen LH, Sharma M, Bordey A (2023) 4E-BP1 expression in embryonic postmitotic neurons mitigates mTORC1-induced cortical malformations and behavioral seizure severity but does not prevent epilepsy in mice. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2023.1257056","journal-title":"Front Neurosci"},{"key":"5553_CR181","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/brain\/awab390","volume":"145","author":"LH Nguyen","year":"2022","unstructured":"Nguyen LH, Xu Y, Mahadeo T et al (2022) Expression of 4E-BP1 in juvenile mice alleviates mTOR-induced neuronal dysfunction and epilepsy. Brain 145:1310\u20131325. https:\/\/doi.org\/10.1093\/brain\/awab390","journal-title":"Brain"},{"key":"5553_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00580-4","volume":"10","author":"SE Leonhard","year":"2024","unstructured":"Leonhard SE, Papri N, Querol L et al (2024) Guillain-Barr\u00e9 syndrome. Nat Rev Dis Primers 10:97. https:\/\/doi.org\/10.1038\/s41572-024-00580-4","journal-title":"Nat Rev Dis Primers"},{"key":"5553_CR183","doi-asserted-by":"publisher","unstructured":"Bellanti R, Rinaldi S (2024) <scp>Guillain\u2010Barr\u00e9<\/scp> syndrome: a comprehensive review. Eur J Neurol 31. https:\/\/doi.org\/10.1111\/ene.16365","DOI":"10.1111\/ene.16365"},{"key":"5553_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1078197","author":"M Yu","year":"2023","unstructured":"Yu M, Nie S, Qiao Y, Ma Y (2023) Guillain-barre syndrome following COVID-19 vaccines: a review of literature. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1078197","journal-title":"Front Immunol"},{"key":"5553_CR185","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","volume":"92","author":"EFM Wijdicks","year":"2017","unstructured":"Wijdicks EFM, Klein CJ (2017) Guillain-Barr\u00e9 syndrome. Mayo Clin Proc 92:467\u2013479. https:\/\/doi.org\/10.1016\/j.mayocp.2016.12.002","journal-title":"Mayo Clin Proc"},{"key":"5553_CR186","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3390\/cells11182897","volume":"11","author":"V Paunovic","year":"2022","unstructured":"Paunovic V, Peric S, Vukovic I et al (2022) Downregulation of LKB1\/AMPK signaling in blood mononuclear cells is associated with the severity of Guillain-Barre syndrome. Cells 11:2897. https:\/\/doi.org\/10.3390\/cells11182897","journal-title":"Cells"},{"key":"5553_CR187","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T et al (2023) The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry 28:3243\u20133256. https:\/\/doi.org\/10.1038\/s41380-022-01661-0","journal-title":"Mol Psychiatry"},{"key":"5553_CR188","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2022-100760","volume":"35","author":"K Levenberg","year":"2022","unstructured":"Levenberg K, Cordner ZA (2022) Bipolar depression: a review of treatment options. Gen Psychiatr 35:e100760. https:\/\/doi.org\/10.1136\/gpsych-2022-100760","journal-title":"Gen Psychiatr"},{"key":"5553_CR189","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ (2018) Depression. Lancet 392:2299\u20132312. https:\/\/doi.org\/10.1016\/S0140-6736(18)31948-2","journal-title":"Lancet"},{"key":"5553_CR190","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jnc.15652","volume":"166","author":"V Lewis","year":"2023","unstructured":"Lewis V, Rodrigue B, Arsenault E et al (2023) Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders. J Neurochem 166:10\u201323. https:\/\/doi.org\/10.1111\/jnc.15652","journal-title":"J Neurochem"},{"key":"5553_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-025-02301-z","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Xu C, Liu J et al (2025) Targeting the complement-mTOR-autophagy axis: the role of apolipoprotein E in depression. BMC Biol 23:228. https:\/\/doi.org\/10.1186\/s12915-025-02301-z","journal-title":"BMC Biol"},{"key":"5553_CR192","doi-asserted-by":"publisher","unstructured":"Cholewinski T, Pereira D, Moerland M, Jacobs GE (2021) MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants. Ther Adv Psychopharmacol 11. https:\/\/doi.org\/10.1177\/20451253211036814","DOI":"10.1177\/20451253211036814"},{"key":"5553_CR193","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","volume":"401","author":"S Marwaha","year":"2023","unstructured":"Marwaha S, Palmer E, Suppes T et al (2023) Novel and emerging treatments for major depression. Lancet 401:141\u2013153. https:\/\/doi.org\/10.1016\/S0140-6736(22)02080-3","journal-title":"Lancet"},{"key":"5553_CR194","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","volume":"35","author":"CS Jernigan","year":"2011","unstructured":"Jernigan CS, Goswami DB, Austin MC et al (2011) The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 35:1774\u20131779. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.05.010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5553_CR195","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.biopsych.2022.10.007","volume":"93","author":"B Singh","year":"2023","unstructured":"Singh B, Vande Voort JL, Riva-Posse P et al (2023) Ketamine-associated change in anhedonia and mTOR expression in treatment-resistant depression. Biol Psychiatry 93:e65\u2013e68. https:\/\/doi.org\/10.1016\/j.biopsych.2022.10.007","journal-title":"Biol Psychiatry"},{"key":"5553_CR196","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu R-J et al (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959\u2013964. https:\/\/doi.org\/10.1126\/science.1190287","journal-title":"Science"},{"key":"5553_CR197","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1017\/S1461145711001702","volume":"15","author":"JM Dwyer","year":"2012","unstructured":"Dwyer JM, Lepack AE, Duman RS (2012) mTOR activation is required for the antidepressant effects of mGluR2\/3 blockade. Int J Neuropsychopharmacol 15:429\u2013434. https:\/\/doi.org\/10.1017\/S1461145711001702","journal-title":"Int J Neuropsychopharmacol"},{"key":"5553_CR198","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1017\/S1461145714000534","volume":"17","author":"SW Park","year":"2014","unstructured":"Park SW, Lee JG, Seo MK et al (2014) Differential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons. Int J Neuropsychopharmacol 17:1831\u20131846. https:\/\/doi.org\/10.1017\/S1461145714000534","journal-title":"Int J Neuropsychopharmacol"},{"key":"5553_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/srep16024","volume":"5","author":"X-L Liu","year":"2015","unstructured":"Liu X-L, Luo L, Mu R-H et al (2015) Fluoxetine regulates mTOR signalling in a region-dependent manner in depression-like mice. Sci Rep 5:16024. https:\/\/doi.org\/10.1038\/srep16024","journal-title":"Sci Rep"},{"key":"5553_CR200","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbr.2016.06.057","volume":"313","author":"F Zhuang","year":"2016","unstructured":"Zhuang F, Li M, Gao X et al (2016) The antidepressant-like effect of alarin is related to TrkB-mTOR signaling and synaptic plasticity. Behav Brain Res 313:158\u2013171. https:\/\/doi.org\/10.1016\/j.bbr.2016.06.057","journal-title":"Behav Brain Res"},{"key":"5553_CR201","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/mp.2017.124","volume":"22","author":"ZD Kabir","year":"2017","unstructured":"Kabir ZD, Che A, Fischer DK et al (2017) Rescue of impaired sociability and anxiety-like behavior in adult cacna1c-deficient mice by pharmacologically targeting eIF2\u03b1. Mol Psychiatry 22:1096\u20131109. https:\/\/doi.org\/10.1038\/mp.2017.124","journal-title":"Mol Psychiatry"},{"key":"5553_CR202","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpsychires.2014.02.003","volume":"53","author":"H Backes","year":"2014","unstructured":"Backes H, Dietsche B, Nagels A et al (2014) Genetic variation in CACNA1C affects neural processing in major depression. J Psychiatr Res 53:38\u201346. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.02.003","journal-title":"J Psychiatr Res"},{"key":"5553_CR203","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41386-020-0705-0","volume":"45","author":"K Fukumoto","year":"2020","unstructured":"Fukumoto K, Foga\u00e7a MV, Liu R-J et al (2020) Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation. Neuropsychopharmacology 45:1725\u20131734. https:\/\/doi.org\/10.1038\/s41386-020-0705-0","journal-title":"Neuropsychopharmacology"},{"key":"5553_CR204","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41398-022-02290-5","volume":"12","author":"M Shen","year":"2022","unstructured":"Shen M, Lv D, Liu X, Wang C (2022) ERK\/mTOR signaling may underlying the antidepressant actions of rapastinel in mice. Transl Psychiatry 12:522. https:\/\/doi.org\/10.1038\/s41398-022-02290-5","journal-title":"Transl Psychiatry"},{"key":"5553_CR205","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/biomedicines11030860","volume":"11","author":"A Alhaddad","year":"2023","unstructured":"Alhaddad A, Radwan A, Mohamed NA et al (2023) Rosiglitazone mitigates dexamethasone-induced depression in mice via modulating brain glucose metabolism and AMPK\/mTOR signaling pathway. Biomedicines 11:860. https:\/\/doi.org\/10.3390\/biomedicines11030860","journal-title":"Biomedicines"},{"key":"5553_CR206","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.neuron.2021.03.008","volume":"109","author":"AM Vanderplow","year":"2021","unstructured":"Vanderplow AM, Eagle AL, Kermath BA et al (2021) Akt-mTOR hypoactivity in bipolar disorder gives rise to cognitive impairments associated with altered neuronal structure and function. Neuron 109:1479-1496.e6. https:\/\/doi.org\/10.1016\/j.neuron.2021.03.008","journal-title":"Neuron"},{"key":"5553_CR207","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1038\/s41380-021-01135-9","volume":"26","author":"R Chadha","year":"2021","unstructured":"Chadha R, Alganem K, Mccullumsmith RE, Meador-Woodruff JH (2021) mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain. Mol Psychiatry 26:6868\u20136879. https:\/\/doi.org\/10.1038\/s41380-021-01135-9","journal-title":"Mol Psychiatry"},{"key":"5553_CR208","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1139\/cjpp-2023-0107","volume":"102","author":"N-A Lashgari","year":"2024","unstructured":"Lashgari N-A, Roudsari NM, Shamsnia HS et al (2024) TLR\/mTOR inflammatory signaling pathway: novel insight for the treatment of schizophrenia. Can J Physiol Pharmacol 102:150\u2013160. https:\/\/doi.org\/10.1139\/cjpp-2023-0107","journal-title":"Can J Physiol Pharmacol"},{"key":"5553_CR209","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2008.01.020","volume":"434","author":"SC Yoon","year":"2008","unstructured":"Yoon SC, Seo MS, Kim SH et al (2008) The effect of MK-801 on mTOR\/p70S6K and translation-related proteins in rat frontal cortex. Neurosci Lett 434:23\u201328. https:\/\/doi.org\/10.1016\/j.neulet.2008.01.020","journal-title":"Neurosci Lett"},{"key":"5553_CR210","doi-asserted-by":"publisher","unstructured":"Bowling H, Zhang G, Bhattacharya A, et al (2014) Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity. Sci Signal 7. https:\/\/doi.org\/10.1126\/scisignal.2004331","DOI":"10.1126\/scisignal.2004331"},{"key":"5553_CR211","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41398-021-01778-w","volume":"12","author":"C Zhuo","year":"2022","unstructured":"Zhuo C, Xu Y, Hou W et al (2022) Mechanistic\/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy. Transl Psychiatry 12:13. https:\/\/doi.org\/10.1038\/s41398-021-01778-w","journal-title":"Transl Psychiatry"},{"key":"5553_CR212","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00225","author":"MS Mostaid","year":"2017","unstructured":"Mostaid MS, Lee TT, Chana G et al (2017) Peripheral transcription of NRG-ErbB pathway genes are upregulated in treatment-resistant schizophrenia. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2017.00225","journal-title":"Front Psychiatry"},{"key":"5553_CR213","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/1567202618999210505124235","volume":"18","author":"K Maiese","year":"2021","unstructured":"Maiese K (2021) Novel insights for multiple sclerosis and demyelinating disorders with apoptosis, autophagy, FoxO, and mTOR. Curr Neurovasc Res 18:169\u2013171. https:\/\/doi.org\/10.2174\/1567202618999210505124235","journal-title":"Curr Neurovasc Res"},{"key":"5553_CR214","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158077","volume":"23","author":"AG Vakrakou","year":"2022","unstructured":"Vakrakou AG, Alexaki A, Brinia M-E et al (2022) The mTOR signaling pathway in multiple sclerosis; from animal models to human data. Int J Mol Sci 23:8077. https:\/\/doi.org\/10.3390\/ijms23158077","journal-title":"Int J Mol Sci"},{"key":"5553_CR215","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis \u2013 a review. Eur J Neurol 26:27\u201340. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"key":"5553_CR216","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s11011-020-00590-7","volume":"35","author":"F Akbarian","year":"2020","unstructured":"Akbarian F, Tabatabaiefar MA, Shaygannejad V et al (2020) Upregulation of MTOR, RPS6KB1, and EIF4EBP1 in the whole blood samples of Iranian patients with multiple sclerosis compared to healthy controls. Metab Brain Dis 35:1309\u20131316. https:\/\/doi.org\/10.1007\/s11011-020-00590-7","journal-title":"Metab Brain Dis"},{"key":"5553_CR217","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/jir.2021.0206","volume":"42","author":"PA Borim","year":"2022","unstructured":"Borim PA, Mimura LAN, Zorzella-Pezavento SFG et al (2022) Effect of rapamycin on MOG-reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis. J Interferon Cytokine Res 42:153\u2013160. https:\/\/doi.org\/10.1089\/jir.2021.0206","journal-title":"J Interferon Cytokine Res"},{"key":"5553_CR218","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1083\/jcb.200903003","volume":"187","author":"W Li","year":"2009","unstructured":"Li W, DeBella LR, Guven-Ozkan T et al (2009) An eIF4E-binding protein regulates katanin protein levels in C. elegans embryos. J Cell Biol 187:33\u201342. https:\/\/doi.org\/10.1083\/jcb.200903003","journal-title":"J Cell Biol"},{"key":"5553_CR219","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jinsphys.2011.04.014","volume":"57","author":"S-H Gu","year":"2011","unstructured":"Gu S-H, Young S-C, Tsai W-H et al (2011) Involvement of 4E-BP phosphorylation in embryonic development of the silkworm, Bombyx mori. J Insect Physiol 57:978\u2013985. https:\/\/doi.org\/10.1016\/j.jinsphys.2011.04.014","journal-title":"J Insect Physiol"},{"key":"5553_CR220","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1093\/humrep\/dez196","volume":"34","author":"S-F Moraveji","year":"2019","unstructured":"Moraveji S-F, Esfandiari F, Taleahmad S et al (2019) Suppression of transforming growth factor-beta signaling enhances spermatogonial proliferation and spermatogenesis recovery following chemotherapy. Hum Reprod 34:2430\u20132442. https:\/\/doi.org\/10.1093\/humrep\/dez196","journal-title":"Hum Reprod"},{"key":"5553_CR221","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.alcohol.2020.08.002","volume":"89","author":"OB Sawant","year":"2020","unstructured":"Sawant OB, Meng C, Wu G, Washburn SE (2020) Prenatal alcohol exposure and maternal glutamine supplementation alter the mTOR signaling pathway in ovine fetal cerebellum and skeletal muscle. Alcohol 89:93\u2013102. https:\/\/doi.org\/10.1016\/j.alcohol.2020.08.002","journal-title":"Alcohol"},{"key":"5553_CR222","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/acer.14348","volume":"44","author":"J Lee","year":"2020","unstructured":"Lee J, Lunde-Young R, Naik V et al (2020) Chronic binge alcohol exposure during pregnancy alters mTOR system in rat fetal hippocampus. Alcohol Clin Exp Res 44:1329\u20131336. https:\/\/doi.org\/10.1111\/acer.14348","journal-title":"Alcohol Clin Exp Res"},{"key":"5553_CR223","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005506","author":"M Hennig","year":"2017","unstructured":"Hennig M, Fiedler S, Jux C et al (2017) Prenatal mechanistic target of rapamycin complex 1 (mTORC1) inhibition by rapamycin treatment of pregnant mice causes intrauterine growth restriction and alters postnatal cardiac growth, morphology, and function. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.005506","journal-title":"J Am Heart Assoc"},{"key":"5553_CR224","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.788969","author":"T-H Hung","year":"2021","unstructured":"Hung T-H, Wu C-P, Chen S-F (2021) Differential changes in Akt and AMPK phosphorylation regulating mTOR activity in the placentas of pregnancies complicated by fetal growth restriction and gestational diabetes mellitus with large-for-gestational age infants. Front Med Lausanne. https:\/\/doi.org\/10.3389\/fmed.2021.788969","journal-title":"Front Med Lausanne"},{"key":"5553_CR225","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1007\/s12035-022-02785-8","volume":"59","author":"S Choi","year":"2022","unstructured":"Choi S, Kang D, Kang J et al (2022) The role of zinc in axon formation via the mTORC1 pathway. Mol Neurobiol 59:3206\u20133217. https:\/\/doi.org\/10.1007\/s12035-022-02785-8","journal-title":"Mol Neurobiol"},{"key":"5553_CR226","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3346\/jkms.2012.27.10.1241","volume":"27","author":"IS Moon","year":"2012","unstructured":"Moon IS, Lee HJ, Park IS (2012) Dendritic eIF4E-binding protein 1 (eIF4E-BP1) mRNA is upregulated by neuronal activation. J Korean Med Sci 27:1241. https:\/\/doi.org\/10.3346\/jkms.2012.27.10.1241","journal-title":"J Korean Med Sci"},{"key":"5553_CR227","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5607\/en.2019.28.2.172","volume":"28","author":"S Choi","year":"2019","unstructured":"Choi S, Sadra A, Kang J et al (2019) Farnesylation-defective Rheb increases axonal length independently of mTORC1 activity in embryonic primary neurons. Exp Neurobiol 28:172\u2013182. https:\/\/doi.org\/10.5607\/en.2019.28.2.172","journal-title":"Exp Neurobiol"},{"key":"5553_CR228","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainres.2010.04.010","volume":"1336","author":"J-T Xu","year":"2010","unstructured":"Xu J-T, Zhao X, Yaster M, Tao Y-X (2010) Expression and distribution of mTOR, p70S6K, 4E-BP1, and their phosphorylated counterparts in rat dorsal root ganglion and spinal cord dorsal horn. Brain Res 1336:46\u201357. https:\/\/doi.org\/10.1016\/j.brainres.2010.04.010","journal-title":"Brain Res"},{"key":"5553_CR229","doi-asserted-by":"publisher","first-page":"112430","DOI":"10.1016\/j.biopha.2021.112430","volume":"145","author":"Y Ding","year":"2022","unstructured":"Ding Y, Chen Q (2022) mTOR pathway: A potential therapeutic target for spinal cord injury. Biomed Pharmacother 145:112430. https:\/\/doi.org\/10.1016\/j.biopha.2021.112430","journal-title":"Biomed Pharmacother"},{"key":"5553_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9060593","volume":"9","author":"I Vargova","year":"2021","unstructured":"Vargova I, Machova Urdzikova L, Karova K et al (2021) Involvement of mTOR pathways in recovery from spinal cord injury by modulation of autophagy and immune response. Biomedicines 9:593. https:\/\/doi.org\/10.3390\/biomedicines9060593","journal-title":"Biomedicines"},{"key":"5553_CR231","doi-asserted-by":"crossref","unstructured":"Lister KC, Wong C, Uttam S, et al (2024) Translational control in the spinal cord regulates gene expression and pain hypersensitivity in the chronic phase of neuropathic pain","DOI":"10.7554\/eLife.100451"},{"key":"5553_CR232","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.rvsc.2017.03.011","volume":"114","author":"L-X Su","year":"2017","unstructured":"Su L-X, Shi X-X, Yang P et al (2017) Effects of tiletamine on the adenosine monophosphate-activated protein kinase signaling pathway in the rat central nervous system. Res Vet Sci 114:101\u2013108. https:\/\/doi.org\/10.1016\/j.rvsc.2017.03.011","journal-title":"Res Vet Sci"},{"key":"5553_CR233","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.1115","volume":"12","author":"Y Yao","year":"2021","unstructured":"Yao Y, Li Y, Ni W et al (2021) Systematic study of immune cell diversity in ischemic postconditioning using high-dimensional single-cell analysis with mass cytometry. Aging Dis 12:812. https:\/\/doi.org\/10.14336\/AD.2020.1115","journal-title":"Aging Dis"},{"key":"5553_CR234","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.3390\/molecules27165295","volume":"27","author":"B Mao","year":"2022","unstructured":"Mao B, Zhang Q, Ma L et al (2022) Overview of research into mTOR inhibitors. Molecules 27:5295. https:\/\/doi.org\/10.3390\/molecules27165295","journal-title":"Molecules"},{"key":"5553_CR235","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","volume":"22","author":"ES Ali","year":"2022","unstructured":"Ali ES, Mitra K, Akter S et al (2022) Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Cancer Cell Int 22:284. https:\/\/doi.org\/10.1186\/s12935-022-02706-8","journal-title":"Cancer Cell Int"},{"key":"5553_CR236","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1076855","author":"X Chen","year":"2023","unstructured":"Chen X, An Y, Tan M et al (2023) Biological functions and research progress of eIF4E. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1076855","journal-title":"Front Oncol"},{"key":"5553_CR237","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ddstr.2009.12.001","volume":"6","author":"Q Liu","year":"2009","unstructured":"Liu Q, Thoreen C, Wang J et al (2009) mTOR mediated anti-cancer drug discovery. Drug Discov Today Ther Strateg 6:47\u201355. https:\/\/doi.org\/10.1016\/j.ddstr.2009.12.001","journal-title":"Drug Discov Today Ther Strateg"},{"key":"5553_CR238","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1172\/JCI44145","volume":"121","author":"SA Wander","year":"2011","unstructured":"Wander SA, Hennessy BT, Slingerland JM (2011) Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest 121:1231\u20131241. https:\/\/doi.org\/10.1172\/JCI44145","journal-title":"J Clin Invest"},{"key":"5553_CR239","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.2174\/1568026615666150610125856","volume":"15","author":"J Jahrling","year":"2015","unstructured":"Jahrling J, Laberge R-M (2015) Age-related neurodegeneration prevention through mTOR inhibition: potential mechanisms and remaining questions. Curr Top Med Chem 15:2139\u20132151. https:\/\/doi.org\/10.2174\/1568026615666150610125856","journal-title":"Curr Top Med Chem"},{"key":"5553_CR240","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1109653","volume":"366","author":"J Baselga","year":"2012","unstructured":"Baselga J, Campone M, Piccart M et al (2012) Everolimus in postmenopausal hormone-receptor\u2013positive advanced breast cancer. N Engl J Med 366:520\u2013529. https:\/\/doi.org\/10.1056\/NEJMoa1109653","journal-title":"N Engl J Med"},{"key":"5553_CR241","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1586\/17512433.2013.827397","volume":"6","author":"MM Mita","year":"2013","unstructured":"Mita MM, Gong J, Chawla SP (2013) Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas. Expert Rev Clin Pharmacol 6:465\u2013482. https:\/\/doi.org\/10.1586\/17512433.2013.827397","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5553_CR242","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9207.1","volume":"5","author":"J Xie","year":"2016","unstructured":"Xie J, Wang X, Proud CG (2016) mTOR inhibitors in cancer therapy. F1000Res 5:2078. https:\/\/doi.org\/10.12688\/f1000research.9207.1","journal-title":"F1000Res"},{"key":"5553_CR243","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1173240","author":"L Wang","year":"2024","unstructured":"Wang L, Qiu Q, Yang D et al (2024) Clinical research progress of ridaforolimus (AP23573, MK8668) over the past decade: a systemic review. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1173240","journal-title":"Front Pharmacol"},{"key":"5553_CR244","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1021\/acs.jmedchem.1c00536","volume":"65","author":"R Shams","year":"2022","unstructured":"Shams R, Matsukawa A, Ochi Y et al (2022) In silico and in cell hybrid selection of nonrapalog ligands to allosterically inhibit the kinase activity of mTORC1. J Med Chem 65:1329\u20131341. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00536","journal-title":"J Med Chem"},{"key":"5553_CR245","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1042\/BST0390456","volume":"39","author":"G Marshall","year":"2011","unstructured":"Marshall G, Howard Z, Dry J et al (2011) Benefits of mTOR kinase targeting in oncology: pre-clinical evidence with AZD8055. Biochem Soc Trans 39:456\u2013459. https:\/\/doi.org\/10.1042\/BST0390456","journal-title":"Biochem Soc Trans"},{"key":"5553_CR246","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.bmcl.2013.01.019","volume":"23","author":"KG Pike","year":"2013","unstructured":"Pike KG, Malagu K, Hummersone MG et al (2013) Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014. Bioorg Med Chem Lett 23:1212\u20131216. https:\/\/doi.org\/10.1016\/j.bmcl.2013.01.019","journal-title":"Bioorg Med Chem Lett"},{"key":"5553_CR247","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.1021\/jm101144f","volume":"53","author":"Q Liu","year":"2010","unstructured":"Liu Q, Chang JW, Wang J et al (2010) Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1 H )-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer. J Med Chem 53:7146\u20137155. https:\/\/doi.org\/10.1021\/jm101144f","journal-title":"J Med Chem"},{"key":"5553_CR248","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen CC, Kang SA, Chang JW et al (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284:8023\u20138032. https:\/\/doi.org\/10.1074\/jbc.M900301200","journal-title":"J Biol Chem"},{"key":"5553_CR249","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/jm101520v","volume":"54","author":"Q Liu","year":"2011","unstructured":"Liu Q, Wang J, Kang SA et al (2011) Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h ][1,6]naphthyridin-2(1 H )-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer. J Med Chem 54:1473\u20131480. https:\/\/doi.org\/10.1021\/jm101520v","journal-title":"J Med Chem"},{"key":"5553_CR250","doi-asserted-by":"publisher","unstructured":"Coleman N, Stephen B, Fu S, et al (2024) Phase I study of sapanisertib (CB\u2010228\/TAK\u2010228\/MLN0128) in combination with ziv\u2010aflibercept in patients with advanced solid tumors. Cancer Med 13. https:\/\/doi.org\/10.1002\/cam4.6877","DOI":"10.1002\/cam4.6877"},{"key":"5553_CR251","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s10637-018-0578-9","volume":"36","author":"L Graham","year":"2018","unstructured":"Graham L, Banda K, Torres A et al (2018) A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer. Invest New Drugs 36:458\u2013467. https:\/\/doi.org\/10.1007\/s10637-018-0578-9","journal-title":"Invest New Drugs"},{"key":"5553_CR252","doi-asserted-by":"publisher","first-page":"55083","DOI":"10.18632\/oncotarget.10397","volume":"7","author":"Z Zeng","year":"2016","unstructured":"Zeng Z, Wang R-Y, Qiu YH et al (2016) MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem\/ progenitor cells. Oncotarget 7:55083\u201355097. https:\/\/doi.org\/10.18632\/oncotarget.10397","journal-title":"Oncotarget"},{"key":"5553_CR253","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/leu.2012.276","volume":"27","author":"MR Janes","year":"2013","unstructured":"Janes MR, Vu C, Mallya S et al (2013) Efficacy of the investigational mTOR kinase inhibitor MLN0128\/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia 27:586\u2013594. https:\/\/doi.org\/10.1038\/leu.2012.276","journal-title":"Leukemia"},{"key":"5553_CR254","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1078-0432.CCR-13-2136","volume":"20","author":"TJ Hayman","year":"2014","unstructured":"Hayman TJ, Wahba A, Rath BH et al (2014) The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells. Clin Cancer Res 20:110\u2013119. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2136","journal-title":"Clin Cancer Res"},{"key":"5553_CR255","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nature17963","volume":"534","author":"VS Rodrik-Outmezguine","year":"2016","unstructured":"Rodrik-Outmezguine VS, Okaniwa M, Yao Z et al (2016) Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature 534:272\u2013276. https:\/\/doi.org\/10.1038\/nature17963","journal-title":"Nature"},{"key":"5553_CR256","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111172","volume":"125","author":"N Wang","year":"2023","unstructured":"Wang N, Zhou K, Liang Z et al (2023) Rapalink-1 outperforms rapamycin in alleviating allogeneic graft rejection by inhibiting the mTORC1-4E-BP1 pathway in mice. Int Immunopharmacol 125:111172. https:\/\/doi.org\/10.1016\/j.intimp.2023.111172","journal-title":"Int Immunopharmacol"},{"key":"5553_CR257","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.21873\/anticanres.15302","volume":"41","author":"T Negayama","year":"2021","unstructured":"Negayama T, Ishibashi Y, Nakamura O et al (2021) Rapalink-1 and hydroxychloroquine exhibit an additive effect in undifferentiated pleomorphic sarcoma by inducing apoptosis. Anticancer Res 41:4885\u20134894. https:\/\/doi.org\/10.21873\/anticanres.15302","journal-title":"Anticancer Res"},{"key":"5553_CR258","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01012","author":"F La Manna","year":"2020","unstructured":"La Manna F, De Menna M, Patel N et al (2020) Dual-mTOR inhibitor Rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.01012","journal-title":"Front Oncol"},{"key":"5553_CR259","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/cas.14395","volume":"111","author":"K Kuroshima","year":"2020","unstructured":"Kuroshima K, Yoshino H, Okamura S et al (2020) Potential new therapy of Rapalink-1, a new generation mammalian target of rapamycin inhibitor, against sunitinib-resistant renal cell carcinoma. Cancer Sci 111:1607\u20131618. https:\/\/doi.org\/10.1111\/cas.14395","journal-title":"Cancer Sci"},{"key":"5553_CR260","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-08-1385","volume":"68","author":"V Serra","year":"2008","unstructured":"Serra V, Markman B, Scaltriti M et al (2008) NVP-BEZ235, a dual PI3K\/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations. Cancer Res 68:8022\u20138030. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1385","journal-title":"Cancer Res"},{"key":"5553_CR261","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01345","author":"PMQ Bellozi","year":"2019","unstructured":"Bellozi PMQ, Gomes GF, de Oliveira LR et al (2019) NVP-BEZ235 (dactolisib) has protective effects in a transgenic mouse model of Alzheimer\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2019.01345","journal-title":"Front Pharmacol"},{"key":"5553_CR262","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.24272\/j.issn.2095-8137.2023.294","volume":"44","author":"X-W Zhang","year":"2023","unstructured":"Zhang X-W, Zhu X-X, Tang D-S, Lu J-H (2023) Targeting autophagy in Alzheimer\u2019s disease: animal models and mechanisms. Zool Res 44:1132\u20131145. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2023.294","journal-title":"Zool Res"},{"key":"5553_CR263","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1021\/ml900028r","volume":"1","author":"SD Knight","year":"2010","unstructured":"Knight SD, Adams ND, Burgess JL et al (2010) Discovery of GSK2126458, a highly potent inhibitor of PI3K and the mammalian target of rapamycin. ACS Med Chem Lett 1:39\u201343. https:\/\/doi.org\/10.1021\/ml900028r","journal-title":"ACS Med Chem Lett"},{"key":"5553_CR264","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-4-5","volume":"4","author":"GP Delcuve","year":"2012","unstructured":"Delcuve GP, Khan DH, Davie JR (2012) Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics 4:5. https:\/\/doi.org\/10.1186\/1868-7083-4-5","journal-title":"Clin Epigenetics"},{"key":"5553_CR265","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000448843","volume":"105","author":"H Freitag","year":"2017","unstructured":"Freitag H, Christen F, Lewens F et al (2017) Inhibition of mTOR\u2019s catalytic site by PKI-587 is a promising therapeutic option for gastroenteropancreatic neuroendocrine tumor disease. Neuroendocrinology 105:90\u2013104. https:\/\/doi.org\/10.1159\/000448843","journal-title":"Neuroendocrinology"},{"key":"5553_CR266","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1016\/S2352-3026(18)30030-9","volume":"5","author":"JR Brown","year":"2018","unstructured":"Brown JR, Hamadani M, Hayslip J et al (2018) Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial. Lancet Haematol 5:e170\u2013e180. https:\/\/doi.org\/10.1016\/S2352-3026(18)30030-9","journal-title":"Lancet Haematol"},{"key":"5553_CR267","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1021\/jm2009327","volume":"54","author":"DP Sutherlin","year":"2011","unstructured":"Sutherlin DP, Bao L, Berry M et al (2011) Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)\/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer. J Med Chem 54:7579\u20137587. https:\/\/doi.org\/10.1021\/jm2009327","journal-title":"J Med Chem"},{"key":"5553_CR268","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1021\/acs.jmedchem.8b01825","volume":"62","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yuan X, Zhang W et al (2019) Discovery of novel dual histone deacetylase and mammalian target of rapamycin target inhibitors as a promising strategy for cancer therapy. J Med Chem 62:1577\u20131592. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01825","journal-title":"J Med Chem"},{"key":"5553_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113824","volume":"225","author":"S Zhai","year":"2021","unstructured":"Zhai S, Zhang H, Chen R et al (2021) Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma. Eur J Med Chem 225:113824. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113824","journal-title":"Eur J Med Chem"},{"key":"5553_CR270","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2018.12.005","volume":"177","author":"AB Pupyshev","year":"2019","unstructured":"Pupyshev AB, Tikhonova MA, Akopyan AA et al (2019) Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson\u2019s disease. Pharmacol Biochem Behav 177:1\u201311. https:\/\/doi.org\/10.1016\/j.pbb.2018.12.005","journal-title":"Pharmacol Biochem Behav"},{"key":"5553_CR271","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010095","volume":"10","author":"S de Wet","year":"2021","unstructured":"de Wet S, Du Toit A, Loos B (2021) Spermidine and rapamycin reveal distinct autophagy flux response and cargo receptor clearance profile. Cells 10:95. https:\/\/doi.org\/10.3390\/cells10010095","journal-title":"Cells"},{"key":"5553_CR272","doi-asserted-by":"crossref","unstructured":"Freitag K, Sterczyk N, Obermayer B, et al (2021) The autophagy activator Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer\u2019s disease mouse model","DOI":"10.1101\/2021.10.28.466219"},{"key":"5553_CR273","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1094351","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Tamilanban T, Alsayari A et al (2022) Trilateral association of autophagy, mTOR and Alzheimer\u2019s disease: potential pathway in the development for Alzheimer\u2019s disease therapy. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1094351","journal-title":"Front Pharmacol"},{"key":"5553_CR274","doi-asserted-by":"publisher","unstructured":"Sekiyama N, Arthanari H, Papadopoulos E, et al (2015) Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1. Proc Nat Acad Sci 112. https:\/\/doi.org\/10.1073\/pnas.1512118112","DOI":"10.1073\/pnas.1512118112"},{"key":"5553_CR275","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jid.2020.08.021","volume":"141","author":"RK Srivastava","year":"2021","unstructured":"Srivastava RK, Khan J, Arumugam A et al (2021) 5\u2032-cap-dependent translation as a potent therapeutic target for lethal human squamous cell carcinoma. J Invest Dermatol 141:742-753.e10. https:\/\/doi.org\/10.1016\/j.jid.2020.08.021","journal-title":"J Invest Dermatol"},{"key":"5553_CR276","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10637-017-0535-z","volume":"36","author":"A De","year":"2018","unstructured":"De A, Jacobson BA, Peterson MS et al (2018) 4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma. Invest New Drugs 36:217\u2013229. https:\/\/doi.org\/10.1007\/s10637-017-0535-z","journal-title":"Invest New Drugs"},{"key":"5553_CR277","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1073\/pnas.1011477108","volume":"108","author":"R Cencic","year":"2011","unstructured":"Cencic R, Hall DR, Robert F et al (2011) Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. Proc Natl Acad Sci U S A 108:1046\u20131051. https:\/\/doi.org\/10.1073\/pnas.1011477108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5553_CR278","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00834","author":"GR Kardos","year":"2020","unstructured":"Kardos GR, Gowda R, Dinavahi SS et al (2020) Salubrinal in combination with 4E1RCat synergistically impairs melanoma development by disrupting the protein synthetic machinery. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.00834","journal-title":"Front Oncol"},{"key":"5553_CR279","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3810\/pgm.2009.05.2014","volume":"121","author":"A Riner","year":"2009","unstructured":"Riner A, Chan-Tack KM, Murray JS (2009) Original research: intravenous ribavirin\u2014review of the FDA\u2019s emergency investigational new drug database (1997\u20132008) and literature review. Postgrad Med 121:5\u201315. https:\/\/doi.org\/10.3810\/pgm.2009.05.2014","journal-title":"Postgrad Med"},{"key":"5553_CR280","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3109\/10428194.2010.496506","volume":"51","author":"KLB Borden","year":"2010","unstructured":"Borden KLB, Culjkovic-Kraljacic B (2010) Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? Leuk Lymphoma 51:1805\u20131815. https:\/\/doi.org\/10.3109\/10428194.2010.496506","journal-title":"Leuk Lymphoma"},{"key":"5553_CR281","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1038\/s41388-018-0567-7","volume":"38","author":"KA Urtishak","year":"2019","unstructured":"Urtishak KA, Wang L-S, Culjkovic-Kraljacic B et al (2019) Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia. Oncogene 38:2241\u20132262. https:\/\/doi.org\/10.1038\/s41388-018-0567-7","journal-title":"Oncogene"},{"key":"5553_CR282","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/hed.24938","volume":"40","author":"LA Dunn","year":"2018","unstructured":"Dunn LA, Fury MG, Sherman EJ et al (2018) Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA\/IVB human papillomavirus-associated oropharyngeal squamous cell cancer. Head Neck 40:233\u2013241. https:\/\/doi.org\/10.1002\/hed.24938","journal-title":"Head Neck"},{"key":"5553_CR283","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109689","volume":"73","author":"X Yang","year":"2020","unstructured":"Yang X, Zhong W, Cao R (2020) Phosphorylation of the mRNA cap-binding protein eIF4E and cancer. Cell Signal 73:109689. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109689","journal-title":"Cell Signal"},{"key":"5553_CR284","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbrc.2016.02.120","volume":"472","author":"J Li","year":"2016","unstructured":"Li J, Huang Y, Gao Y et al (2016) Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-\u03b2-catenin axis. Biochem Biophys Res Commun 472:299\u2013305. https:\/\/doi.org\/10.1016\/j.bbrc.2016.02.120","journal-title":"Biochem Biophys Res Commun"},{"key":"5553_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109773","volume":"352","author":"X Qi","year":"2022","unstructured":"Qi X, Zhang S, Chen Z et al (2022) EGPI-1, a novel eIF4E\/eIF4G interaction inhibitor, inhibits lung cancer cell growth and angiogenesis through Ras\/MNK\/ERK\/eIF4E signaling pathway. Chem Biol Interact 352:109773. https:\/\/doi.org\/10.1016\/j.cbi.2021.109773","journal-title":"Chem Biol Interact"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05553-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:38:06Z","timestamp":1764020286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05553-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":285,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5553"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05553-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sets"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}